[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_140c879a-e960-4144-b9b3-a855dfcb24ac":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:140c879a-e960-4144-b9b3-a855dfcb24ac,\"}":101},{"code":4,"data":5,"meta":17},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":19,"manageAffiliations":36,"indexDatabases":60,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},"140c879a-e960-4144-b9b3-a855dfcb24ac","2023-12-05T06:40:56.552+00:00","2025-11-21T10:01:14.871+00:00",[],"HPB",{"issn":12,"title":14},{"VOID":13},"1365182X",{"EN":10},"PUBLISHER","PENDING",null,4,[20,28],{"id":21,"createTime":22,"updateTime":23,"relativeEntities":24,"label":25,"description":27,"parentId":17,"standard":17,"scholarHubFieldId":17},"01203b2d-e9ba-432d-a4b0-d0f3ced5dfa6","2023-05-29T10:24:07.274+00:00","2023-11-21T07:04:43.214+00:00",[],{"EN":26},"Hepatology",{},{"id":29,"createTime":30,"updateTime":31,"relativeEntities":32,"label":33,"description":35,"parentId":17,"standard":17,"scholarHubFieldId":17},"a520f91c-9c10-4000-96b1-c80ea7776e25","2023-05-29T10:24:12.053+00:00","2023-11-21T07:53:13.948+00:00",[],{"EN":34},"Gastroenterology",{},[37,49],{"id":38,"createTime":39,"updateTime":40,"relativeEntities":41,"slug":42,"properties":43,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":47,"url":17,"parentIds":48,"statistic":17},"85fc6dd3-e353-4ce6-9d33-a98bddca22e8","2023-05-29T12:06:36.475+00:00","2024-02-19T17:14:20.667+00:00",[],"ELSEVIER-SCI-LTD",{"title":44},{"EN":45},"ELSEVIER SCI LTD","AFFILIATION",10,[],{"id":50,"createTime":51,"updateTime":52,"relativeEntities":53,"slug":54,"properties":55,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":58,"url":17,"parentIds":59,"statistic":17},"2ea55c76-ecc2-4e81-94b5-baabc3f11863","2023-05-29T10:24:16.606+00:00","2024-02-20T15:28:41.845+00:00",[],"John-Wiley-Sons-Inc-",{"title":56},{"EN":57},"John Wiley & Sons Inc.",8,[],[61,81],{"id":62,"indexDatabase":63,"url":77,"indexYears":17,"academicFieldIds":78,"indexDatabaseRanking":17},"4a061a0e-da96-43bd-9b54-173b4c504cd5",{"id":64,"createTime":65,"updateTime":66,"relativeEntities":67,"label":68,"description":70,"key":73,"publicationTags":74,"standard":17},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":69,"VI":69},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":71,"EN":72},"Cơ sở dữ liệu SCIE","SCIE database","scie",[75,76],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1365-182X",[79,80],"4b2c1694-c69d-4b20-b2eb-9687848dfb30","1feaf4f7-c4fe-4c9f-aa70-8cd93767f200",{"id":82,"indexDatabase":83,"url":95,"indexYears":96,"academicFieldIds":97,"indexDatabaseRanking":100},"3e3def62-e2d7-4f12-b206-0ac9772a2bfd",{"id":84,"createTime":85,"updateTime":86,"relativeEntities":87,"label":88,"description":90,"key":92,"publicationTags":93,"standard":17},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":89,"VI":89},"Scopus - Elsevier",{"EN":89,"VI":91},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[94],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F28367","2000-2025",[98,99],"34ca0c58-3b99-4064-9bf3-a754a6e2e9a7","d39aa686-8d5d-45f0-81c4-13c21a0f2f39","SCOPUS__Q3",{"meta":102,"data":104},{"total":103},"1397",[105,277,373,479,691,864,985,1132,1414,1575],{"id":106,"createTime":107,"updateTime":108,"relativeEntities":109,"slug":110,"properties":111,"entityType":118,"verifyStatus":119,"verifyTime":108,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":122,"fullTextUrl":17,"authors":123,"publicationType":245,"publisherRelationship":246,"citationCount":17,"citationInfo":17,"publishDate":274,"publishYear":275,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"7d9e87b4-e7aa-4b86-85dd-baa63242c5fe","2023-12-06T13:14:59.219+00:00","2024-12-09T23:59:42.130+00:00",[],"Outcomes-of-double-layer-continuous-suture-hepaticojejunostomy-in-pancreatoduodenectomy-and-total-pancreatectomy",{"references":112,"title":114,"doi":116},{"VOID":113},"Asano, 2016, Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy, J Hepatobiliary Pancreat Sci, 23, 628, 10.1002\u002Fjhbp.385\nNagakawa, 2021, Incidence of anastomotic stricture after hepaticojejunostomy with continuous sutures in patients who underwent laparoscopic pancreaticoduodenectomy, Surg Today, 51, 1212, 10.1007\u002Fs00595-020-02223-z\nMalgras, 2016, Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors, HPB (Oxford), 18, 367, 10.1016\u002Fj.hpb.2015.10.012\nJester, 2017, The impact of hepaticojejunostomy leaks after pancreatoduodenectomy: a devastating source of morbidity and mortality, J Gastrointest Surg, 21, 1017, 10.1007\u002Fs11605-017-3406-1\nDuconseil, 2014, Biliary complications after pancreaticoduodenectomy: skinny bile ducts are surgeons' enemies, World J Surg, 38, 2946, 10.1007\u002Fs00268-014-2698-5\nSuzuki, 2003, Factors influencing hepaticojejunostomy leak following pancreaticoduodenal resection; importance of anastomotic leak test, Hepato-Gastroenterology, 50, 254\nAndrianello, 2017, Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies, HPB (Oxford), 19, 264, 10.1016\u002Fj.hpb.2016.11.011\nHerzog, 2014, Management of isolated bile leaks after pancreatic resections, J Invest Surg, 27, 273, 10.3109\u002F08941939.2014.916368\nEl Nakeeb, 2019, Biliary leakage following pancreaticoduodenectomy: prevalence, risk factors and management, Hepatobiliary Pancreat Dis Int, 18, 67, 10.1016\u002Fj.hbpd.2018.10.005\nHouse, 2006, Incidence and outcome of biliary strictures after pancreaticoduodenectomy, Ann Surg, 243, 571, 10.1097\u002F01.sla.0000216285.07069.fc\nDimou, 2016, Incidence of hepaticojejunostomy stricture after hepaticojejunostomy, Surgery, 160, 691, 10.1016\u002Fj.surg.2016.05.021\nZhu, 2017, Bilioenteric anastomotic stricture in patients with benign and malignant tumors: prevalence, risk factors and treatment, Hepatobiliary Pancreat Dis Int, 16, 412, 10.1016\u002FS1499-3872(17)60033-X\nNatsume, 2021, Continuous suture is a risk factor for benign hepaticojejunostomy stenosis after pancreatoduodenectomy in patients with a non-dilated bile duct, HPB (Oxford), 10.1016\u002Fj.hpb.2021.04.010\nOkabayashi, 2018, Incidence and risk factors of cholangitis after hepaticojejunostomy, J Gastrointest Surg, 22, 676, 10.1007\u002Fs11605-017-3532-9\nAbdelRafee, 2015, Long-term follow-up of 120 patients after hepaticojejunostomy for treatment of post-cholecystectomy bile duct injuries: a retrospective cohort study, Int J Surg, 18, 205, 10.1016\u002Fj.ijsu.2015.05.004\nBrown, 2021, Video review reveals technical factors predictive of biliary stricture and cholangitis after robotic pancreaticoduodenectomy, HPB (Oxford), 23, 144, 10.1016\u002Fj.hpb.2020.05.013\nBurkhart, 2013, Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy, J Gastrointest Surg, 17, 451, 10.1007\u002Fs11605-012-2118-9\nZhou, 2018, Substantial atherosclerotic celiac axis stenosis is a new risk factor for biliary fistula after pancreaticoduodenectomy, Int J Surg, 49, 62, 10.1016\u002Fj.ijsu.2017.11.054\nTraverso, 1989, Pancreaticoduodenectomy. The importance of preserving hepatic blood flow to prevent biliary fistula, Am Surg, 55, 421\nBrunner, 2018, Continuous or interrupted suture technique for hepaticojejunostomy? A national survey, BMC Surg, 18, 84, 10.1186\u002Fs12893-018-0418-z\nWorld Medical Association, 2013, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects, JAMA, 310, 2191, 10.1001\u002Fjama.2013.281053\nvon Elm, 2014, The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Int J Surg, 12, 1495, 10.1016\u002Fj.ijsu.2014.07.013\nKoch, 2011, Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery, Surgery, 149, 680, 10.1016\u002Fj.surg.2010.12.002\nBassi, 2017, The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 tears after, Surgery, 161, 584, 10.1016\u002Fj.surg.2016.11.014\nWente, 2007, Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS), Surgery, 142, 761, 10.1016\u002Fj.surg.2007.05.005\nWente, 2007, Postpancreatectomy hemorrhage (PPH): an international study group of pancreatic surgery (ISGPS) definition, Surgery, 142, 20, 10.1016\u002Fj.surg.2007.02.001\nDindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097\u002F01.sla.0000133083.54934.ae\nSlankamenac, 2013, The comprehensive complication index: a novel continuous scale to measure surgical morbidity, Ann Surg, 258, 1, 10.1097\u002FSLA.0b013e318296c732\nMenonna, 2021, Additional modifications to the Blumgart pancreaticojejunostomy: results of a propensity score-matched analysis versus Cattel-Warren pancreaticojejunostomy, Surgery, 169, 954, 10.1016\u002Fj.surg.2020.08.013\nKwon, 2020, Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: a single-center experience with 109 patients, Medicine (Baltim), 99, 10.1097\u002FMD.0000000000022115\nSlieker, 2012, Significant contribution of the portal vein to blood flow through the common bile duct, Ann Surg, 255, 523, 10.1097\u002FSLA.0b013e31824714d0\nBustos, 2020, Robotic hepaticojejunostomy: surgical technique and risk factor analysis for anastomotic leak and stenosis, HPB (Oxford), 22, 1442, 10.1016\u002Fj.hpb.2020.02.007\nLiu, 2021, Perioperative and oncological outcomes of robotic versus open pancreaticoduodenectomy in low-risk surgical candidates: a multicenter propensity score-matched study, Ann Surg\nShi, 2020, Short-term outcomes after robot-assisted vs open pancreaticoduodenectomy after the learning curve, JAMA Surg, 155, 389, 10.1001\u002Fjamasurg.2020.0021\nTerblanche, 1983, An ischemic basis for biliary strictures, Surgery, 94, 52\nNorthover, 1979, A new look at the arterial supply of the bile duct in man and its surgical implications, Br J Surg, 66, 379, 10.1002\u002Fbjs.1800660603\nAmmori, 2000, Biliary strictures complicating pancreaticoduodenectomy, Int J Pancreatol, 28, 15, 10.1385\u002FIJGC:28:1:15\nUeda, 2017, Refractory long-term cholangitis after pancreaticoduodenectomy: a retrospective study, World J Surg, 41, 1882, 10.1007\u002Fs00268-017-3912-z\nRoque, 2015, Preoperative drainage for malignant biliary strictures: is it time for self-expanding metallic stents?, Clin Endosc, 48, 8, 10.5946\u002Fce.2015.48.1.8\nLee, 2014, Histological changes in the bile duct after long-term placement of a fully covered self-expandable metal stent within a common bile duct: a canine study, Clin Endosc, 47, 84, 10.5946\u002Fce.2014.47.1.84\nBakhru, 2011, Fully covered self-expanding metal stents placed temporarily in the bile duct: safety profile and histologic classification in a porcine model, BMC Gastroenterol, 11, 76, 10.1186\u002F1471-230X-11-76",{"EN":115},"Outcomes of double-layer continuous suture hepaticojejunostomy in pancreatoduodenectomy and total pancreatectomy",{"VOID":117},"10.1016\u002Fj.hpb.2022.05.005","PUBLICATION","VERIFIED","Auto Verify",0,"https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X2200140X",[124,141,154,167,179,192,204,220,233],{"id":125,"sortIndex":126,"researcher":17,"roles":127,"affiliations":129,"properties":138},"6d2f726e-75c1-4254-9054-a64d7f5762fe",3,[128],"AUTHOR",[130],{"id":17,"sortIndex":121,"affiliation":131,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":134,"slug":17,"properties":135,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"5605f68b-76ae-4f15-961c-1872e9a06e18","2024-01-11T02:43:13.963+00:00",[],{"title":136},{"VI":137},"Division of General and Transplant Surgery, University of Pisa, Pisa, Italy",{"title":139},{"VI":140},"Michael Ginesini",{"id":142,"sortIndex":143,"researcher":17,"roles":144,"affiliations":145,"properties":151},"ca56156f-446a-4126-ad91-31db89bb37b0",1,[128],[146],{"id":17,"sortIndex":121,"affiliation":147,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":148,"slug":17,"properties":149,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":150},{"VI":137},{"title":152},{"VI":153},"Emanuele F. Kauffmann",{"id":155,"sortIndex":156,"researcher":17,"roles":157,"affiliations":158,"properties":164},"498212b1-6fec-4e85-8196-920a1f1207ab",5,[128],[159],{"id":17,"sortIndex":121,"affiliation":160,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":161,"slug":17,"properties":162,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":163},{"VI":137},{"title":165},{"VI":166},"Cesare Gianfaldoni",{"id":168,"sortIndex":121,"researcher":17,"roles":169,"affiliations":170,"properties":176},"25f2d4c0-67b6-4d5e-97d5-4293efc77c62",[128],[171],{"id":17,"sortIndex":121,"affiliation":172,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":173,"slug":17,"properties":174,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":175},{"VI":137},{"title":177},{"VI":178},"Niccolò Napoli",{"id":180,"sortIndex":181,"researcher":17,"roles":182,"affiliations":183,"properties":189},"319de639-f394-4df0-9dd9-b0d56a5286ec",7,[128],[184],{"id":17,"sortIndex":121,"affiliation":185,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":186,"slug":17,"properties":187,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":188},{"VI":137},{"title":190},{"VI":191},"Fabio Vistoli",{"id":193,"sortIndex":58,"researcher":17,"roles":194,"affiliations":195,"properties":201},"11df0abf-0b02-4f08-b11e-9ce1983f793d",[128],[196],{"id":17,"sortIndex":121,"affiliation":197,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":198,"slug":17,"properties":199,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":200},{"VI":137},{"title":202},{"VI":203},"Ugo Boggi",{"id":205,"sortIndex":206,"researcher":17,"roles":207,"affiliations":208,"properties":217},"73c86bba-2105-453d-890b-ba8eb26d7bed",6,[128],[209],{"id":17,"sortIndex":121,"affiliation":210,"properties":17},{"id":211,"createTime":212,"updateTime":212,"relativeEntities":213,"slug":17,"properties":214,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"78e94de0-89ac-45dd-8796-1d382616793e","2023-12-06T13:14:59.303+00:00",[],{"title":215},{"VI":216},"Division of Anesthesia and Intensive Care, University of Pisa, Pisa, Italy",{"title":218},{"VI":219},"Gabriella Amorese",{"id":221,"sortIndex":222,"researcher":17,"roles":223,"affiliations":224,"properties":230},"b08f5629-1422-4e9c-b1c5-64b3eac6c8f4",2,[128],[225],{"id":17,"sortIndex":121,"affiliation":226,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":227,"slug":17,"properties":228,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":229},{"VI":137},{"title":231},{"VI":232},"Rosilde Caputo",{"id":234,"sortIndex":18,"researcher":17,"roles":235,"affiliations":236,"properties":242},"a7edee3a-9398-45fb-8ab6-99ab5db63d79",[128],[237],{"id":17,"sortIndex":121,"affiliation":238,"properties":17},{"id":132,"createTime":133,"updateTime":133,"relativeEntities":239,"slug":17,"properties":240,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":241},{"VI":137},{"title":243},{"VI":244},"Fabio Asta","ARTICLE",{"url":122,"publisher":247,"properties":269},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":248,"slug":10,"properties":249,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":252,"manageAffiliations":253,"indexDatabases":254,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":250,"title":251},{"VOID":13},{"EN":10},[],[],[255,262],{"id":82,"indexDatabase":256,"url":95,"indexYears":96,"academicFieldIds":261,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":257,"label":258,"description":259,"key":92,"publicationTags":260,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":263,"url":77,"indexYears":17,"academicFieldIds":268,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":264,"label":265,"description":266,"key":73,"publicationTags":267,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":270,"pages":272},{"VOID":271},"24",{"VOID":273},"1738-1747","2022-10-01",2022,false,{"id":278,"createTime":279,"updateTime":280,"relativeEntities":281,"slug":282,"properties":283,"entityType":118,"verifyStatus":119,"verifyTime":280,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":290,"fullTextUrl":17,"authors":291,"publicationType":245,"publisherRelationship":343,"citationCount":17,"citationInfo":17,"publishDate":371,"publishYear":372,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"cc523f46-ee47-494e-8d0e-b6b7db437ad6","2024-01-15T12:09:20.181+00:00","2024-12-21T23:56:21.715+00:00",[],"Central-venous-pressure-and-liver-resection-a-systematic-review-and-meta-analysis",{"references":284,"title":286,"doi":288},{"VOID":285},"Cescon, 2009, Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years, Ann Surg, 249, 995, 10.1097\u002FSLA.0b013e3181a63c74\nJarnagin, 2002, Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade, Ann Surg, 236, 397, 10.1097\u002F00000658-200210000-00001\nCoolsen, 2013, A systematic review of outcomes in patients undergoing liver surgery in an enhanced recovery after surgery pathways, HPB, 15, 245, 10.1111\u002Fj.1477-2574.2012.00572.x\nHughes, 2014, Enhanced recovery following liver surgery: a systematic review and meta analysis, HPB, 16, 699, 10.1111\u002Fhpb.12245\nPoon, 2004, Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database, Ann Surg, 240, 698, 10.1097\u002F01.sla.0000141195.66155.0c\nde Boer, 2007, Impact of blood loss on outcome after liver resection, Dig Surg, 24, 259, 10.1159\u002F000103656\nGurusamy, 2012, Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection, Cochrane Database Syst Rev, 5, Cd007338\nMoher, 2009, Preferred reporting items for systematic reviews and meta analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371\u002Fjournal.pmed.1000097\nHozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Med Res Methodol, 5, 13, 10.1186\u002F1471-2288-5-13\n2011\nEl Kharboutly, 2004, The role of adoption of low central venous pressure in hepatic resection with pringle manoeuvre in reducing blood loss and improving operative outcome, Egypt J Anaesth, 20, 369\nFigueras, 2005, Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial, Ann Surg, 241, 582, 10.1097\u002F01.sla.0000157168.26021.b8\nKato, 2008, Effect of infra hepatic inferior vena cava clamping on bleeding during hepatic dissection: a prospective, randomized, controlled study, World J Surg, 32, 1082, 10.1007\u002Fs00268-007-9445-0\nLiu, 2005, Application of low central venous pressure in liver resection, Zhonghua Gandan Waike Zazhi., 11, 461\nLiu, 2008, Effect of controlled low central venous pressure on renal function in major liver resection, Chin Germ J Clin Oncol, 7, 7, 10.1007\u002Fs10330-007-0128-y\nRahbari, 2011, Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial, Ann Surg, 253, 1102, 10.1097\u002FSLA.0b013e318214bee5\nWang, 2006, Low central venous pressure reduces blood loss in hepatectomy, World J Gastroenterol, 12, 935, 10.3748\u002Fwjg.v12.i6.935\nZhu, 2012, Randomized clinical trial comparing infrahepatic inferior vena cava clamping with low central venous pressure in complex liver resections involving the Pringle manoeuvre, The British journal of surgery., 99, 781, 10.1002\u002Fbjs.8714\nRyu, 2010, Low central venous pressure with milrinone during living donor hepatectomy, Am J Transplant, 10, 877, 10.1111\u002Fj.1600-6143.2010.03051.x\nSand, 2011, Effect of patient position and PEEP on hepatic, portal and central venous pressures during liver resection, Acta Anaesthesiol Scand, 55, 1106, 10.1111\u002Fj.1399-6576.2011.02502.x\nLin, 2013, Optimal central venous pressure during partial hepatectomy for hepatocellular carcinoma, Hepatobiliary Pancreat Dis Int, 12, 520, 10.1016\u002FS1499-3872(13)60082-X\nLi, 2014, Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy, World J Gastroenterol, 20, 303, 10.3748\u002Fwjg.v20.i1.303\nAyanoglu, 2003, Anesthetic management and complications in living donor hepatectomy, Transpl Proc, 35, 2970, 10.1016\u002Fj.transproceed.2003.10.090\nJones, 1998, Central venous pressure and its effect on blood loss during liver resection, Br J Surg, 85, 1058, 10.1046\u002Fj.1365-2168.1998.00795.x\nMelendez, 1998, Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction, J Am Coll Surg, 187, 620, 10.1016\u002FS1072-7515(98)00240-3\nMoug, 2007, Selective continuous vascular occlusion and perioperative fluid restriction in partial hepatectomy. Outcomes in 101 consecutive patients, Eur J Surg Oncol, 33, 1036, 10.1016\u002Fj.ejso.2007.01.028\nBui, 2002, Minimising blood loss and transfusion requirements in hepatic resection, HPB, 4, 5, 10.1080\u002F136518202753598672\nChen, 2000, Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality, J Gastrointest Surg, 4, 162, 10.1016\u002FS1091-255X(00)80052-9\nChhibber, 2007, Anesthesia care for adult live donor hepatectomy: our experiences with 100 cases, Liver Transpl, 13, 537, 10.1002\u002Flt.21074\nKim, 2009, Association between central venous pressure and blood loss during hepatic resection in 984 living donors, Acta Anaesthesiol Scand, 53, 601, 10.1111\u002Fj.1399-6576.2009.01920.x\nLeelanukrom, 2013, Factors affecting intraoperative blood loss during liver resection. Journal of the Medical Association of Thailand =, Chotmaihet thangphaet, 96, 58\nOtsubo, 2004, Bleeding during hepatectomy can be reduced by clamping the inferior vena cava below the liver, Surgery, 135, 67, 10.1016\u002FS0039-6060(03)00343-X\nPalmon, 1997, Venous air embolism: a review, J Clin Anesth, 9, 251, 10.1016\u002FS0952-8180(97)00024-X\nPage, 2008, Epidural analgesia in hepatic resection, J Am Coll Surg, 206, 1184, 10.1016\u002Fj.jamcollsurg.2007.12.041\nEid, 2005, Low central venous pressure anesthesia in major hepatic resection, Middle East J Anaesthesiol, 18, 367\nGustafsson, 2012, Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations, Clin Nutr, 31, 783, 10.1016\u002Fj.clnu.2012.08.013\nMiyazaki, 2005, Spinal epidural hematoma after removal of an epidural catheter: case report and review of the literature, J Spinal Disord Tech, 18, 547, 10.1097\u002F01.bsd.0000128692.44276.cf\nKoea, 2009, Fast track liver resection: the effect of a comprehensive care package and analgesia with single dose intrathecal morphine with gabapentin or continuous epidural analgesia, HPB Surg, 2009, 271986, 10.1155\u002F2009\u002F271986\nRevie, 2012, Randomized clinical trial of local infiltration plus patient controlled opiate analgesia vs. epidural analgesia following liver resection surgery, HPB, 14, 611, 10.1111\u002Fj.1477-2574.2012.00490.x\nWu, 1996, Effects and limitations of prolonged intermittent ischaemia for hepatic resection of the cirrhotic liver, The British journal of surgery., 83, 121, 10.1002\u002Fbjs.1800830139\nFu, 2011, A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy, Am J Surg, 201, 62, 10.1016\u002Fj.amjsurg.2009.09.029\nNi, 2013, A prospective randomized controlled trial to compare pringle manoeuvre with hemi hepatic vascular inflow occlusion in liver resection for hepatocellular carcinoma with cirrhosis, J Gastrointest Surg, 17, 1414, 10.1007\u002Fs11605-013-2236-z",{"EN":287},"Central venous pressure and liver resection: a systematic review and meta analysis",{"VOID":289},"10.1111\u002Fhpb.12462","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X15311278",[292,307,319,331],{"id":293,"sortIndex":126,"researcher":17,"roles":294,"affiliations":295,"properties":304},"ad4ab205-b3a3-46f0-8680-5b135bc01bed",[128],[296],{"id":17,"sortIndex":121,"affiliation":297,"properties":17},{"id":298,"createTime":299,"updateTime":299,"relativeEntities":300,"slug":17,"properties":301,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"85fe6c23-9342-43a9-b231-09dbd51f67b6","2024-01-15T12:09:20.201+00:00",[],{"title":302},{"VI":303},"Department of Clinical Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK",{"title":305},{"VI":306},"Stephen J. Wigmore",{"id":308,"sortIndex":143,"researcher":17,"roles":309,"affiliations":310,"properties":316},"ecf58258-2792-4656-aea1-4e55470d8b8a",[128],[311],{"id":17,"sortIndex":121,"affiliation":312,"properties":17},{"id":298,"createTime":299,"updateTime":299,"relativeEntities":313,"slug":17,"properties":314,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":315},{"VI":303},{"title":317},{"VI":318},"Nicholas T. Ventham",{"id":320,"sortIndex":222,"researcher":17,"roles":321,"affiliations":322,"properties":328},"9db1ac2e-6c26-4bb0-af68-e993a00abc64",[128],[323],{"id":17,"sortIndex":121,"affiliation":324,"properties":17},{"id":298,"createTime":299,"updateTime":299,"relativeEntities":325,"slug":17,"properties":326,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":327},{"VI":303},{"title":329},{"VI":330},"Ewen M. Harrison",{"id":332,"sortIndex":121,"researcher":17,"roles":333,"affiliations":334,"properties":340},"a4f698cc-9e31-492e-80d2-38c77dc708e7",[128],[335],{"id":17,"sortIndex":121,"affiliation":336,"properties":17},{"id":298,"createTime":299,"updateTime":299,"relativeEntities":337,"slug":17,"properties":338,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":339},{"VI":303},{"title":341},{"VI":342},"Michael J. Hughes",{"url":290,"publisher":344,"properties":366},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":345,"slug":10,"properties":346,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":349,"manageAffiliations":350,"indexDatabases":351,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":347,"title":348},{"VOID":13},{"EN":10},[],[],[352,359],{"id":82,"indexDatabase":353,"url":95,"indexYears":96,"academicFieldIds":358,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":354,"label":355,"description":356,"key":92,"publicationTags":357,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":360,"url":77,"indexYears":17,"academicFieldIds":365,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":361,"label":362,"description":363,"key":73,"publicationTags":364,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":367,"pages":369},{"VOID":368},"17",{"VOID":370},"863-871","2015-10-01",2015,{"id":374,"createTime":375,"updateTime":375,"relativeEntities":376,"slug":17,"properties":377,"entityType":118,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":384,"fullTextUrl":17,"authors":385,"publicationType":245,"publisherRelationship":449,"citationCount":17,"citationInfo":17,"publishDate":477,"publishYear":478,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"50943909-309a-46dc-bc1d-9fc51d79360f","2023-12-05T23:54:26.511+00:00",[],{"references":378,"title":380,"doi":382},{"VOID":379},"Lowenfels, 2009, The changing character of acute pancreatitis: epidemiology, etiology, and prognosis, Curr Gastroenterol Rep, 11, 97, 10.1007\u002Fs11894-009-0016-4\nFrossard, 2008, Acute pancreatitis, Lancet, 371, 143, 10.1016\u002FS0140-6736(08)60107-5\nImrie, 1995, Prognosis of acute pancreatitis, Ann Ital Chir, 66, 187\nAnand, 2012, Modern management of acute pancreatitis, Gastroenterol Clin N Am, 41, 1, 10.1016\u002Fj.gtc.2011.12.013\nButer, 2002, Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis, Br J Surg, 89, 298, 10.1046\u002Fj.0007-1323.2001.02025.x\nRanson, 1974, Objective early identification of severe acute pancreatitis, Am J Gastroenterol, 61, 443\nLarvin, 1989, APACHE-II score for assessment and monitoring of acute pancreatitis, Lancet, 2, 201, 10.1016\u002FS0140-6736(89)90381-4\nKhanna, 2013, Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI scores, IL-6, CRP, and procalcitonin in predicting severity, organ failure, pancreatic necrosis, and mortality in acute pancreatitis, HPB, 2013\nOsvaldt, 2001, Evaluation of Ranson, Glasgow, APACHE-II, and APACHE-O criteria to predict severity in acute biliary pancreatitis, Int Surg, 86, 158\nMofidi, 2009, Risk assessment in acute pancreatitis, Br J Surg, 96, 137, 10.1002\u002Fbjs.6431\nPark, 2013, Bedside index for severity in acute pancreatitis: comparison with other scoring systems in predicting severity and organ failure, Hepatobiliary Pancreat Dis Int, 12, 645, 10.1016\u002FS1499-3872(13)60101-0\nBanks, 2013, Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus, Gut, 62, 102, 10.1136\u002Fgutjnl-2012-302779\nWilson, 1989, C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis, Br J Surg, 76, 177, 10.1002\u002Fbjs.1800760224\nStoelben, 1996, [Clinical significance of cytokines Il-6, Il-8 and C-reactive protein in serum of patients with acute pancreatitis], Chirurg, 67, 1231\nMayer, 2002, Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis, Br J Surg, 89, 163, 10.1046\u002Fj.1365-2168.2002.01972.x\nPooran, 2003, Cytokines (IL-6, IL-8, TNF): early and reliable predictors of severe acute pancreatitis, J Clin Gastroenterol, 37, 263, 10.1097\u002F00004836-200309000-00013\nWu, 2011, Blood urea nitrogen in the early assessment of acute pancreatitis: an international validation study, Arch Intern Med, 171, 669, 10.1001\u002Farchinternmed.2011.126\nRiche, 2003, Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis, Surgery, 133, 257, 10.1067\u002Fmsy.2003.70\nPongprasobchai, 2010, Erythrocyte sedimentation rate and C-reactive protein for the prediction of severity of acute pancreatitis, Pancreas, 39, 1226, 10.1097\u002FMPA.0b013e3181deb33e\nCardoso, 2013, C-reactive protein prognostic accuracy in acute pancreatitis: timing of measurement and cutoff points, Eur J Gastroenterol Hepatol, 25, 784, 10.1097\u002FMEG.0b013e32835fd3f0\nDervenis, 2000, Assessments of severity and management of acute pancreatitis based on the Santorini Consensus Conference report, JOP, 1, 178\nMarshall, 1995, Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome, Crit Care Med, 23, 1638, 10.1097\u002F00003246-199510000-00007\nDeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307\u002F2531595\nHeath, 1993, Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis, Gut, 34, 41, 10.1136\u002Fgut.34.1.41\nNeoptolemos, 2000, Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study, Lancet, 355, 1955, 10.1016\u002FS0140-6736(00)02327-8\nAl-Bahrani, 2005, Clinical laboratory assessment of acute pancreatitis, Clin Chim Acta, 362, 26, 10.1016\u002Fj.cccn.2005.06.008\nLankisch, 2009, The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease, Clin Gastroenterol Hepatol, 7, 702, 10.1016\u002Fj.cgh.2009.02.020\nOskarsson, 2011, Validation of the harmless acute pancreatitis score in predicting nonsevere course of acute pancreatitis, Pancreatology, 11, 464, 10.1159\u002F000331502\nThandassery, 2013, Dynamic nature of organ failure in severe acute pancreatitis: the impact of persistent and deteriorating organ failure, HPB, 15, 523, 10.1111\u002Fj.1477-2574.2012.00613.x",{"EN":381},"The predictive value of C-reactive protein (CRP) in acute pancreatitis – is interval change in CRP an additional indicator of severity?",{"VOID":383},"10.1016\u002Fj.hpb.2017.06.001","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X17308195",[386,401,413,425,437],{"id":387,"sortIndex":143,"researcher":17,"roles":388,"affiliations":389,"properties":398},"2c367bcf-c849-4041-9210-c839242fe168",[128],[390],{"id":17,"sortIndex":121,"affiliation":391,"properties":17},{"id":392,"createTime":393,"updateTime":393,"relativeEntities":394,"slug":17,"properties":395,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"cfc4468d-090d-4611-ac86-472ce3126bb4","2023-12-05T23:54:26.525+00:00",[],{"title":396},{"VI":397},"Department of Surgery, Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland",{"title":399},{"VI":400},"Neil R. Moran",{"id":402,"sortIndex":18,"researcher":17,"roles":403,"affiliations":404,"properties":410},"4de36ba2-a079-45d3-ba5e-f69fc8ce7851",[128],[405],{"id":17,"sortIndex":121,"affiliation":406,"properties":17},{"id":392,"createTime":393,"updateTime":393,"relativeEntities":407,"slug":17,"properties":408,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":409},{"VI":397},{"title":411},{"VI":412},"Kevin C. Conlon",{"id":414,"sortIndex":126,"researcher":17,"roles":415,"affiliations":416,"properties":422},"423dadbf-8e01-474f-9fd5-cd51c730a29a",[128],[417],{"id":17,"sortIndex":121,"affiliation":418,"properties":17},{"id":392,"createTime":393,"updateTime":393,"relativeEntities":419,"slug":17,"properties":420,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":421},{"VI":397},{"title":423},{"VI":424},"Paul F. Ridgway",{"id":426,"sortIndex":222,"researcher":17,"roles":427,"affiliations":428,"properties":434},"950efc6f-482b-456c-a1d7-d45376cca0a1",[128],[429],{"id":17,"sortIndex":121,"affiliation":430,"properties":17},{"id":392,"createTime":393,"updateTime":393,"relativeEntities":431,"slug":17,"properties":432,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":433},{"VI":397},{"title":435},{"VI":436},"Michael E. Kelly",{"id":438,"sortIndex":121,"researcher":17,"roles":439,"affiliations":440,"properties":446},"d0968655-b029-419e-9388-012b9507174a",[128],[441],{"id":17,"sortIndex":121,"affiliation":442,"properties":17},{"id":392,"createTime":393,"updateTime":393,"relativeEntities":443,"slug":17,"properties":444,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":445},{"VI":397},{"title":447},{"VI":448},"Aaron D. Stirling",{"url":384,"publisher":450,"properties":472},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":451,"slug":10,"properties":452,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":455,"manageAffiliations":456,"indexDatabases":457,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":453,"title":454},{"VOID":13},{"EN":10},[],[],[458,465],{"id":82,"indexDatabase":459,"url":95,"indexYears":96,"academicFieldIds":464,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":460,"label":461,"description":462,"key":92,"publicationTags":463,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":466,"url":77,"indexYears":17,"academicFieldIds":471,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":467,"label":468,"description":469,"key":73,"publicationTags":470,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":473,"pages":475},{"VOID":474},"19",{"VOID":476},"874-880","2017-10-01",2017,{"id":480,"createTime":481,"updateTime":482,"relativeEntities":483,"slug":484,"properties":485,"entityType":118,"verifyStatus":119,"verifyTime":494,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":495,"fullTextUrl":17,"authors":496,"publicationType":245,"publisherRelationship":659,"citationCount":17,"citationInfo":17,"publishDate":687,"publishYear":688,"citationAnalyzeStatus":689,"lastCitationAnalyze":690,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"0b0908c8-4c75-474a-8084-a206ec25493b","2024-02-06T20:36:16.474+00:00","2025-11-23T23:54:23.102+00:00",[],"Impact-of-neoadjuvant-chemotherapy-and-stereotactic-body-radiation-therapy-SBRT-on-R0-resection-rate-for-borderline-resectable-and-locally-advanced-pancreatic-cancer",{"references":486,"title":488,"doi":490,"gsPaper":492},{"VOID":487},"Siegel, 2019, Cancer statistics, CA Cancer J Clin, 69, 7, 10.3322\u002Fcaac.21551\nConroy, 2018, FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer, N Engl J Med, 379, 2395, 10.1056\u002FNEJMoa1809775\nKatz, 2014, Management of borderline resectable pancreatic cancer, Semin Radiat Oncol, 24, 105, 10.1016\u002Fj.semradonc.2013.11.006\nKrishnan, 2007, Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy, Cancer, 110, 47, 10.1002\u002Fcncr.22735\nHerman, 2015, Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma, Cancer, 121, 1128, 10.1002\u002Fcncr.29161\nKharofa, 2014, Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer, Radiother Oncol, 113, 41, 10.1016\u002Fj.radonc.2014.09.010\nAjani, 2006, Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response, J Clin Oncol, 24, 3953, 10.1200\u002FJCO.2006.06.4840\nDonohoe, 2013, Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard, Ann Surg, 258, 784, 10.1097\u002FSLA.0b013e3182a66588\nFokas, 2014, Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO\u002FARO\u002FAIO-94 trial, J Clin Oncol, 32, 1554, 10.1200\u002FJCO.2013.54.3769\nFokas, 2017, Tumor regression grading after preoperative chemoradiotherapy as a prognostic factor and individual-level surrogate for disease-free survival in rectal cancer, J Natl Cancer Inst, 109, 10.1093\u002Fjnci\u002Fdjx095\nSauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056\u002FNEJMoa040694\nvan Hagen, 2012, Preoperative chemoradiotherapy for esophageal or junctional cancer, N Engl J Med, 366, 2074, 10.1056\u002FNEJMoa1112088\nChuong, 2016, Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer, J Gastrointest Oncol, 7, 221\nDohopolski, 2017, Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival, J Gastrointest Oncol, 8, 766, 10.21037\u002Fjgo.2017.08.04\nMellon, 2017, Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy, Acta Oncol, 56, 391, 10.1080\u002F0284186X.2016.1256497\nWild, 2013, A phase 2 multi-institutional study to evaluate gemcitabine and fractionated stereotactic radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma, Pract Radiat Oncol, 3, S4, 10.1016\u002Fj.prro.2013.01.016\nMellon, 2016, Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer, J Gastrointest Oncol, 7, 547, 10.21037\u002Fjgo.2016.03.15\nMoningi, 2015, The role of stereotactic body radiation therapy for pancreatic cancer: a single-institution experience, Ann Surg Oncol, 22, 2352, 10.1245\u002Fs10434-014-4274-5\nChuong, 2013, Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated, Int J Radiat Oncol Biol Phys, 86, 516, 10.1016\u002Fj.ijrobp.2013.02.022\nSchellenberg, 2008, Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 72, 678, 10.1016\u002Fj.ijrobp.2008.01.051\nSchellenberg, 2011, Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 81, 181, 10.1016\u002Fj.ijrobp.2010.05.006\nMahadevan, 2010, Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 78, 735, 10.1016\u002Fj.ijrobp.2009.08.046\nMahadevan, 2011, Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer, Int J Radiat Oncol Biol Phys, 81, e615, 10.1016\u002Fj.ijrobp.2011.04.045\nZhao, 2012, Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis, Ann Diagn Pathol, 16, 29, 10.1016\u002Fj.anndiagpath.2011.08.005\nConroy, 2011, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, 364, 1817, 10.1056\u002FNEJMoa1011923\nPeron, 2016, An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma, Oncotarget, 7, 82953, 10.18632\u002Foncotarget.12761\nGillen, 2010, Preoperative\u002Fneoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages, PLoS Med, 7, 10.1371\u002Fjournal.pmed.1000267\nGreenblatt, 2011, Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy, Ann Surg Oncol, 18, 2126, 10.1245\u002Fs10434-011-1594-6\nTsuruga, 2013, Portal vein stenosis after pancreatectomy following neoadjuvant chemoradiation therapy for pancreatic cancer, World J Gastroenterol, 19, 2569, 10.3748\u002Fwjg.v19.i16.2569\nVinogradskiy, 2019, The clinical and dosimetric impact of real-time target tracking in pancreatic SBRT, Int J Radiat Oncol Biol Phys, 103, 268, 10.1016\u002Fj.ijrobp.2018.08.021\nStrasberg, 2009, The accordion severity grading system of surgical complications, Ann Surg, 250, 177, 10.1097\u002FSLA.0b013e3181afde41\nKatz, 2009, Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma, Ann Surg Oncol, 16, 836, 10.1245\u002Fs10434-008-0295-2\nWinter, 2006, 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience, J Gastrointest Surg, 10, 1199, 10.1016\u002Fj.gassur.2006.08.018\nNeoptolemos, 2001, Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and\u002For chemotherapy in the ESPAC-1 randomized controlled trial, Ann Surg, 234, 758, 10.1097\u002F00000658-200112000-00007\nMillikan, 1999, Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas, Am Surg, 65, 618, 10.1177\u002F000313489906500704\nMellon, 2015, Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma, Acta Oncol, 54, 979, 10.3109\u002F0284186X.2015.1004367\nKharofa, 2019, Pattern of marginal local failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy for resectable and borderline resectable pancreas cancer, Am J Clin Oncol, 42, 247, 10.1097\u002FCOC.0000000000000518\nKatz, 2016, Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A021101, JAMA Surg, 151, 10.1001\u002Fjamasurg.2016.1137\nAhmad, 2020, Surgical outcome results from SWOG S1505: a randomized clinical trial of mFOLFIRINOX versus gemcitabine\u002Fnab-paclitaxel for perioperative treatment of resectable pancreatic ductal adenocarcinoma, Ann Surg, 272, 481, 10.1097\u002FSLA.0000000000004155\nPalta, 2019, Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline, Pract Radiat Oncol, 9, 322, 10.1016\u002Fj.prro.2019.06.016\nCrane, 2002, Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?, Int J Radiat Oncol Biol Phys, 52, 1293, 10.1016\u002FS0360-3016(01)02740-7\nKim, 2002, Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?, J Gastrointest Surg, 6, 763, 10.1016\u002FS1091-255X(02)00017-3\nHosein, 2012, A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma, BMC Cancer, 12, 199, 10.1186\u002F1471-2407-12-199\nKoong, 2004, Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 58, 1017, 10.1016\u002Fj.ijrobp.2003.11.004\nKoong, 2005, Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 63, 320, 10.1016\u002Fj.ijrobp.2005.07.002\nRwigema, 2011, Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas, Am J Clin Oncol, 34, 63, 10.1097\u002FCOC.0b013e3181d270b4\nChatterjee, 2012, Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome, Cancer, 118, 3182, 10.1002\u002Fcncr.26651\nBaine, 2019, Incidence and patterns of locoregional failure after stereotactic body radiation therapy for pancreatic adenocarcinoma, Pract Radiat Oncol, 9, e29, 10.1016\u002Fj.prro.2018.06.006\nZhu, 2019, Patterns of local failure after stereotactic body radiation therapy and sequential chemotherapy as initial treatment for pancreatic cancer: implications of target volume design, Int J Radiat Oncol Biol Phys, 104, 101, 10.1016\u002Fj.ijrobp.2019.01.075",{"EN":489},"Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer",{"VOID":491},"10.1016\u002Fj.hpb.2020.11.004",{"VOID":493},"[]","2024-05-05T04:28:20.623+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X20312302",[497,513,525,544,556,571,590,605,617,629,644],{"id":498,"sortIndex":499,"researcher":17,"roles":500,"affiliations":501,"properties":510},"12e0c3f7-9d07-4abf-853b-387766baf531",9,[128],[502],{"id":17,"sortIndex":121,"affiliation":503,"properties":17},{"id":504,"createTime":505,"updateTime":505,"relativeEntities":506,"slug":17,"properties":507,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"1a176f41-a1c6-450d-b4e7-2043d89f975f","2024-02-06T20:36:16.591+00:00",[],{"title":508},{"VI":509},"Department of Surgery, University of Colorado School of Medicine, Aurora, CO, USA",{"title":511},{"VI":512},"Richard D. Schulick",{"id":514,"sortIndex":222,"researcher":17,"roles":515,"affiliations":516,"properties":522},"922f66fe-c7e0-41b2-8e52-780f647d3193",[128],[517],{"id":17,"sortIndex":121,"affiliation":518,"properties":17},{"id":504,"createTime":505,"updateTime":505,"relativeEntities":519,"slug":17,"properties":520,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":521},{"VI":509},{"title":523},{"VI":524},"Cheryl Meguid",{"id":526,"sortIndex":121,"researcher":17,"roles":527,"affiliations":528,"properties":541},"979580d5-2326-4e3a-bd0b-9952e7b37d66",[128],[529],{"id":530,"sortIndex":121,"affiliation":531,"properties":538},"fee64866-ca79-4da0-b0eb-34c367537460",{"id":532,"createTime":533,"updateTime":533,"relativeEntities":534,"slug":17,"properties":535,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"b58fa184-9c8b-4441-b6b6-cd4f4e1364c3","2023-12-25T08:48:06.470+00:00",[],{"title":536},{"VI":537},"Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, United States",{"title":539},{"VI":540},"Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA",{"title":542},{"VI":543},"Sara J. Zakem",{"id":545,"sortIndex":126,"researcher":17,"roles":546,"affiliations":547,"properties":553},"e3af72cf-7671-4e7f-81ed-357ef1782639",[128],[548],{"id":17,"sortIndex":121,"affiliation":549,"properties":17},{"id":504,"createTime":505,"updateTime":505,"relativeEntities":550,"slug":17,"properties":551,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":552},{"VI":509},{"title":554},{"VI":555},"Robert J. Torphy",{"id":557,"sortIndex":143,"researcher":17,"roles":558,"affiliations":559,"properties":568},"22c8e5fb-8f60-46ee-a0e3-50fe77a55004",[128],[560],{"id":561,"sortIndex":121,"affiliation":562,"properties":566},"eef479b8-b4dd-4452-8563-28261f1dfe12",{"id":532,"createTime":533,"updateTime":533,"relativeEntities":563,"slug":17,"properties":564,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":565},{"VI":537},{"title":567},{"VI":540},{"title":569},{"VI":570},"Adam C. Mueller",{"id":572,"sortIndex":206,"researcher":17,"roles":573,"affiliations":574,"properties":587},"0c56ba40-7aa5-4e71-b5e8-2e86a999823e",[128],[575],{"id":576,"sortIndex":121,"affiliation":577,"properties":584},"97f60855-c064-4378-ba96-2ed400bf8903",{"id":578,"createTime":579,"updateTime":579,"relativeEntities":580,"slug":17,"properties":581,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"b60eadc4-763f-49db-94bd-56965281f1ad","2023-12-26T00:21:19.892+00:00",[],{"title":582},{"VI":583},"Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, United States",{"title":585},{"VI":586},"Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA",{"title":588},{"VI":589},"Wells A. Messersmith",{"id":591,"sortIndex":156,"researcher":17,"roles":592,"affiliations":593,"properties":602},"d17e6387-a6ad-49fc-87dd-9af504e67ba6",[128],[594],{"id":595,"sortIndex":121,"affiliation":596,"properties":600},"cbc3d3cc-9241-4052-a1aa-0eb4e7b54fd5",{"id":532,"createTime":533,"updateTime":533,"relativeEntities":597,"slug":17,"properties":598,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":599},{"VI":537},{"title":601},{"VI":540},{"title":603},{"VI":604},"Tracey Schefter",{"id":606,"sortIndex":58,"researcher":17,"roles":607,"affiliations":608,"properties":614},"af767124-0749-4629-9e88-4c632e5e3938",[128],[609],{"id":17,"sortIndex":121,"affiliation":610,"properties":17},{"id":504,"createTime":505,"updateTime":505,"relativeEntities":611,"slug":17,"properties":612,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":613},{"VI":509},{"title":615},{"VI":616},"Marco Del Chiaro",{"id":618,"sortIndex":181,"researcher":17,"roles":619,"affiliations":620,"properties":626},"c7e7b4c2-f8aa-4b1d-9b7b-8bbf677050bc",[128],[621],{"id":17,"sortIndex":121,"affiliation":622,"properties":17},{"id":504,"createTime":505,"updateTime":505,"relativeEntities":623,"slug":17,"properties":624,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":625},{"VI":509},{"title":627},{"VI":628},"Martin D. McCarter",{"id":630,"sortIndex":18,"researcher":17,"roles":631,"affiliations":632,"properties":641},"61d1bc3d-383e-4016-9419-a9bcff2e0114",[128],[633],{"id":634,"sortIndex":121,"affiliation":635,"properties":639},"f77b1c22-f075-426d-9781-1d9a0b0c03a5",{"id":532,"createTime":533,"updateTime":533,"relativeEntities":636,"slug":17,"properties":637,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":638},{"VI":537},{"title":640},{"VI":540},{"title":642},{"VI":643},"Douglas E. Holt",{"id":645,"sortIndex":47,"researcher":17,"roles":646,"affiliations":647,"properties":656},"7eeb3ae7-c1fa-419b-8f76-07ff6cb39421",[128],[648],{"id":649,"sortIndex":121,"affiliation":650,"properties":654},"109f354d-3dd8-4a3e-8e6b-41b7d367fdd8",{"id":532,"createTime":533,"updateTime":533,"relativeEntities":651,"slug":17,"properties":652,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":653},{"VI":537},{"title":655},{"VI":540},{"title":657},{"VI":658},"Karyn A. Goodman",{"url":495,"publisher":660,"properties":682},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":661,"slug":10,"properties":662,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":665,"manageAffiliations":666,"indexDatabases":667,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":663,"title":664},{"VOID":13},{"EN":10},[],[],[668,675],{"id":82,"indexDatabase":669,"url":95,"indexYears":96,"academicFieldIds":674,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":670,"label":671,"description":672,"key":92,"publicationTags":673,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":676,"url":77,"indexYears":17,"academicFieldIds":681,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":677,"label":678,"description":679,"key":73,"publicationTags":680,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":683,"pages":685},{"VOID":684},"23",{"VOID":686},"1072-1083","2021-07-01",2021,"ERROR_IN_GET_PLATFORM_ID","2025-11-23T23:54:23.101+00:00",{"id":692,"createTime":693,"updateTime":694,"relativeEntities":695,"slug":696,"properties":697,"entityType":118,"verifyStatus":119,"verifyTime":694,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":704,"fullTextUrl":17,"authors":705,"publicationType":245,"publisherRelationship":834,"citationCount":17,"citationInfo":17,"publishDate":862,"publishYear":863,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"28b5c604-731d-4126-9a59-b0db111b5aac","2023-12-28T05:47:47.935+00:00","2025-01-12T23:53:32.068+00:00",[],"The-effect-of-centralization-on-short-term-outcomes-of-pancreatoduodenectomy-in-a-universal-health-care-system",{"references":698,"title":700,"doi":702},{"VOID":699},"Farges, 2017, The theory and practice of pancreatic surgery in France, Ann Surg, 266, 797, 10.1097\u002FSLA.0000000000002399\nvan Rijssen, 2017, Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit, HPB, 19, 919, 10.1016\u002Fj.hpb.2017.06.010\nKrautz, 2018, Effect of hospital volume on in-hospital morbidity and mortality following pancreatic surgery in Germany, Ann Surg, 267, 411, 10.1097\u002FSLA.0000000000002248\nPerysinakis, 2015, Five-year actual survival after pancreatoduodenectomy for pancreatic head cancer, ANZ J Surg, 85, 183, 10.1111\u002Fans.12422\nJana, 2015, Pancreatic cystic neoplasms: review of current knowledge, diagnostic challenges, and management options, J Carcinog, 14, 3\nvan Dijk, 2018, Systematic review on the impact of pancreatoduodenectomy on quality of life in patients with pancreatic cancer, HPB, 20, 204, 10.1016\u002Fj.hpb.2017.11.002\nCloyd, 2017, Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms, J Surg Oncol, 115, 144, 10.1002\u002Fjso.24499\nZelga, 2015, Negative predictive value of drain amylase concentration for development of pancreatic fistula after pancreaticoduodenectomy, Pancreatology, 15, 179, 10.1016\u002Fj.pan.2014.12.003\nSgroi, 2015, Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma, J Vasc Surg, 61, 475, 10.1016\u002Fj.jvs.2014.09.003\nde Wilde, 2012, Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality, Br J Surg, 99, 404, 10.1002\u002Fbjs.8664\nYoshioka, 2014, Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy, Br J Surg, 101, 523, 10.1002\u002Fbjs.9420\nvan der Geest, 2016, Volume-outcome relationships in pancreatoduodenectomy for cancer, HPB, 18, 317, 10.1016\u002Fj.hpb.2016.01.515\nBalzano, 2016, Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy, HPB, 18, 470, 10.1016\u002Fj.hpb.2015.11.005\nvon Elm, 2008, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, J Clin Epidemiol, 61, 344, 10.1016\u002Fj.jclinepi.2007.11.008\n2017\nLabori, 2017, Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial, BMC Surg, 17, 94, 10.1186\u002Fs12893-017-0291-1\nNOMESCO classification of surgical procedures. https:\u002F\u002Fnorden.diva-portal.org\u002Fsmash\u002Fget\u002Fdiva2:970547\u002FFULLTEXT01.pdf.\nNilssen, 2014, Utilizing national patient-register data to control for comorbidity in prognostic studies, Clin Epidemiol, 6, 395, 10.2147\u002FCLEP.S70742\nSkyrud, 2016, Regional variations in cancer survival: impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway, Int J Cancer, 138, 2190, 10.1002\u002Fijc.29967\nQuan, 2005, Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data, Med Care, 43, 1130, 10.1097\u002F01.mlr.0000182534.19832.83\nLassen, 2018, Benchmarking of aggregated length of stay after open and laparoscopic surgery for cancers of the digestive system, BJS Open, 2, 246, 10.1002\u002Fbjs5.67\nBeane, 2017, Pancreatoduodenectomy with venous or arterial resection: a NSQIP propensity score analysis, HPB, 19, 254, 10.1016\u002Fj.hpb.2016.11.013\n2017\nSwanson, 2014, The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the national cancer data base, Ann Surg Oncol, 21, 4059, 10.1245\u002Fs10434-014-4036-4\nBhayani, 2014, Multivisceral and extended resections during pancreatoduodenectomy increase morbidity and mortality, Surgery, 155, 567, 10.1016\u002Fj.surg.2013.12.020\nPetrucciani, 2018, Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review, HPB, 20, 3, 10.1016\u002Fj.hpb.2017.08.002\nFA-Ohoo, 2016, Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma, Br J Surg, 103, 179, 10.1002\u002Fbjs.9969\nKleive, 2017, Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy, Br J Surg, 104, 1558, 10.1002\u002Fbjs.10603\nKantor, 2018, The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy, HPB, 20, 140, 10.1016\u002Fj.hpb.2017.08.012\nHuang, 2017, Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations, Gut\nOkano, 2015, Postoperative infectious complications after pancreatic resection, Br J Surg, 102, 1551, 10.1002\u002Fbjs.9919\nHu, 2016, Risk factors for postoperative pancreatic fistula: analysis of 539 successive cases of pancreaticoduodenectomy, World J Gastroenterol, 22, 7797, 10.3748\u002Fwjg.v22.i34.7797\nGupta, 2011, Determinants of outcomes in pancreatic surgery and use of hospital resources, J Surg Oncol, 1096\nZhou, 2017, An evidence-based approach to the surgical interventions for severe pancreatic fistula after pancreatoduodenectomy, Surgeon, 16, 119, 10.1016\u002Fj.surge.2017.07.005\nBressan, 2018, Completion pancreatectomy in the acute management of pancreatic fistula after pancreaticoduodenectomy: a systematic review and qualitative synthesis of the literature, HPB, 20, 20, 10.1016\u002Fj.hpb.2017.08.036\nLassen, 2013, Pancreaticoduodenectomy: ERAS recommendations, Clin Nutr, 32, 870, 10.1016\u002Fj.clnu.2013.04.019\nChu, 2017, Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma, HPB, 19, 1046, 10.1016\u002Fj.hpb.2017.04.017\nDerogar, 2015, Hospital teaching status and volume related to mortality after pancreatic cancer surgery in a national cohort, Br J Surg, 102, 548, 10.1002\u002Fbjs.9754\nLassen, 2018, The new national registry for gastrointestinal surgery in Norway: NoRGast, Scand J Surg, 107, 201, 10.1177\u002F1457496918766697",{"EN":701},"The effect of centralization on short term outcomes of pancreatoduodenectomy in a universal health care system",{"VOID":703},"10.1016\u002Fj.hpb.2018.08.011","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X18339418",[706,731,756,782,819],{"id":707,"sortIndex":121,"researcher":17,"roles":708,"affiliations":709,"properties":728},"c9ad3b70-941b-493b-811b-730467e36bbb",[128],[710,720],{"id":711,"sortIndex":143,"affiliation":712,"properties":719},"9a47c989-e8c7-496e-acce-8a082babc06a",{"id":713,"createTime":714,"updateTime":714,"relativeEntities":715,"slug":17,"properties":716,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"82914c79-e029-4eb7-8491-d01b8284acad","2023-12-28T05:47:48.000+00:00",[],{"title":717},{"VI":718},"Institute of Clinical Medicine, The Arctic University of Norway, Hansine Hansens Veg 18, 9019, Tromsø, Norway",{},{"id":17,"sortIndex":121,"affiliation":721,"properties":17},{"id":722,"createTime":723,"updateTime":723,"relativeEntities":724,"slug":17,"properties":725,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"16a3319b-e5d1-4c36-aa4b-0d6b2db0c27b","2023-12-28T05:47:47.947+00:00",[],{"title":726},{"VI":727},"Department of Gastrointestinal Surgery, University Hospital of Northern Norway, Sykehusveien 38, 9019, Tromsø, Norway",{"title":729},{"VI":730},"Linn S. Nymo",{"id":732,"sortIndex":222,"researcher":17,"roles":733,"affiliations":734,"properties":753},"a7980e70-043b-431c-8db5-c523a80b5576",[128],[735,743],{"id":17,"sortIndex":121,"affiliation":736,"properties":17},{"id":737,"createTime":738,"updateTime":738,"relativeEntities":739,"slug":17,"properties":740,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"ed2dc084-6d6c-4fb9-8957-64378ed2869d","2023-12-28T05:47:48.003+00:00",[],{"title":741},{"VI":742},"Department of Hepatobiliary and Pancreatic Surgery, Oslo University Hospital, Postboks 4950 Nydalen, 0424, Oslo, Norway",{"id":744,"sortIndex":143,"affiliation":745,"properties":752},"a3c60e98-ce66-4284-882e-b97cbd7f76b2",{"id":746,"createTime":747,"updateTime":747,"relativeEntities":748,"slug":17,"properties":749,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"c40bc906-f6e9-40fb-b2b9-ab3e25bf5606","2023-12-28T05:47:47.977+00:00",[],{"title":750},{"VI":751},"Institute of Clinical Medicine, University of Oslo, Problemveien 7, 0315, Oslo, Norway",{},{"title":754},{"VI":755},"Dyre Kleive",{"id":757,"sortIndex":18,"researcher":17,"roles":758,"affiliations":759,"properties":779},"9e32a61a-0549-4136-ad3f-c23886a0b4fe",[128],[760,765,772],{"id":17,"sortIndex":121,"affiliation":761,"properties":17},{"id":722,"createTime":723,"updateTime":723,"relativeEntities":762,"slug":17,"properties":763,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":764},{"VI":727},{"id":766,"sortIndex":143,"affiliation":767,"properties":771},"d3fbade3-7a85-43ac-aec4-bf280b2054f5",{"id":713,"createTime":714,"updateTime":714,"relativeEntities":768,"slug":17,"properties":769,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":770},{"VI":718},{},{"id":773,"sortIndex":222,"affiliation":774,"properties":778},"fc490de0-c22d-48b0-8710-a992a781c85a",{"id":737,"createTime":738,"updateTime":738,"relativeEntities":775,"slug":17,"properties":776,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":777},{"VI":742},{},{"title":780},{"VI":781},"Kristoffer Lassen",{"id":783,"sortIndex":143,"researcher":17,"roles":784,"affiliations":785,"properties":816},"df8b38fb-3003-4517-be2a-0bdccbe4efc3",[128],[786,796,808],{"id":787,"sortIndex":143,"affiliation":788,"properties":795},"60fc45c2-f0b5-4695-a0aa-196086c16138",{"id":789,"createTime":790,"updateTime":790,"relativeEntities":791,"slug":17,"properties":792,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"f8e34717-a1e4-4556-ac2e-1dbd882a6c6c","2023-12-28T05:47:47.962+00:00",[],{"title":793},{"VI":794},"Clinical Surgery, Royal Infirmary of Edinburgh and University of Edinburgh, 51 Little France Cres, Edinburgh, EH16 4SA, UK",{},{"id":797,"sortIndex":222,"affiliation":798,"properties":807},"98293d16-dd73-4fb2-8424-173507c94a87",{"id":799,"createTime":800,"updateTime":801,"relativeEntities":802,"slug":803,"properties":804,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"05c1fa70-a124-4aff-9202-94272f0037c3","2023-12-28T05:47:47.965+00:00","2025-06-11T18:54:24.813+00:00",[],"Department-of-Clinical-Medicine-University-of-Bergen-Jonas-Lies-Vei-65-5021-Bergen",{"title":805},{"VI":806},"Department of Clinical Medicine, University of Bergen, Jonas Lies Vei 65, 5021, Bergen",{},{"id":17,"sortIndex":121,"affiliation":809,"properties":17},{"id":810,"createTime":811,"updateTime":811,"relativeEntities":812,"slug":17,"properties":813,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"11c4c306-5d17-4cfa-a8d0-a7c5bb84762d","2023-12-28T05:47:47.959+00:00",[],{"title":814},{"VI":815},"Department of Gastrointestinal Surgery, Stavanger University Hospital, Postboks 8100, 4068, Stavanger, Norway",{"title":817},{"VI":818},"Kjetil Søreide",{"id":820,"sortIndex":126,"researcher":17,"roles":821,"affiliations":822,"properties":831},"475187d8-9bd7-4c96-9088-6df8ae99b0be",[128],[823],{"id":17,"sortIndex":121,"affiliation":824,"properties":17},{"id":825,"createTime":826,"updateTime":826,"relativeEntities":827,"slug":17,"properties":828,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"c2b93453-fd29-48ed-ae6f-87d8d6982b90","2023-12-28T05:47:47.987+00:00",[],{"title":829},{"VI":830},"Centre for Clinical Documentation and Evaluation (SKDE), Northern Norway Regional Health Authority, Sykehusveien 38, 9019, Tromsø, Norway",{"title":832},{"VI":833},"Frank Olsen",{"url":704,"publisher":835,"properties":857},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":836,"slug":10,"properties":837,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":840,"manageAffiliations":841,"indexDatabases":842,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":838,"title":839},{"VOID":13},{"EN":10},[],[],[843,850],{"id":82,"indexDatabase":844,"url":95,"indexYears":96,"academicFieldIds":849,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":845,"label":846,"description":847,"key":92,"publicationTags":848,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":851,"url":77,"indexYears":17,"academicFieldIds":856,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":852,"label":853,"description":854,"key":73,"publicationTags":855,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":858,"pages":860},{"VOID":859},"21",{"VOID":861},"319-327","2019-03-01",2019,{"id":865,"createTime":866,"updateTime":866,"relativeEntities":867,"slug":17,"properties":868,"entityType":118,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":875,"fullTextUrl":17,"authors":876,"publicationType":245,"publisherRelationship":955,"citationCount":17,"citationInfo":17,"publishDate":983,"publishYear":984,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"d52d8c91-5f16-41c5-be40-1d801d823caf","2024-01-16T23:52:48.973+00:00",[],{"references":869,"title":871,"doi":873},{"VOID":870},"Caldwell, 2009, The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology, J Gastroenterol, 44, 96, 10.1007\u002Fs00535-008-2258-6\nPenn, 1991, Hepatic transplantation for primary and metastatic cancers of the liver, Surgery, 110, 726\nIwatsuki, 1985, Role of liver transplantation in cancer therapy, Ann Surg, 202, 401, 10.1097\u002F00000658-198510000-00001\nMazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 334, 693, 10.1056\u002FNEJM199603143341104\nHemming, 2001, Liver transplantation for hepatocellular carcinoma, Ann Surg, 233, 652, 10.1097\u002F00000658-200105000-00009\nFigueras, 2001, Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study, Liver Transpl, 7, 877, 10.1053\u002Fjlts.2001.27856\nBroelsch, 2004, Hepatoma – resection or transplantation, Surg Clin North Am, 84, 495, 10.1016\u002Fj.suc.2003.11.001\nHelton, 2003, Treatment strategies for hepatocellular carcinoma in cirrhosis, J Gastrointest Surg, 7, 401, 10.1016\u002FS1091-255X(02)00161-0\nIsland, 2005, Twenty-year experience with liver transplantation for hepatocellular carcinoma, Arch Surg, 140, 353, 10.1001\u002Farchsurg.140.4.353\nPawlik, 2005, Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma, Liver Transpl, 11, 1086, 10.1002\u002Flt.20472\nShetty, 2004, Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome, Liver Transpl, 10, 911, 10.1002\u002Flt.20140\nJonas, 2001, Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis, Hepatology, 33, 1080, 10.1053\u002Fjhep.2001.23561\nColella, 1997, Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?, Transplant Proc, 29, 492, 10.1016\u002FS0041-1345(96)00221-7\nTamura, 2001, Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation, Arch Surg, 136, 25, 10.1001\u002Farchsurg.136.1.25\nYao, 2001, Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival, Hepatology, 33, 1394, 10.1053\u002Fjhep.2001.24563\nLlovet, 2008, Novel advancements in the management of hepatocellular carcinoma in 2008, J Hepatol, 48, S20, 10.1016\u002Fj.jhep.2008.01.022\nIwatsuki, 2000, Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system, J Am Coll Surg, 191, 389, 10.1016\u002FS1072-7515(00)00688-8\nLlovet, 2002, Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation, Gut, 50, 123, 10.1136\u002Fgut.50.1.123\nOlthoff, 1995, Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma, Ann Surg, 221, 734, 10.1097\u002F00000658-199506000-00012\nLlovet, 2008, Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, 359, 378, 10.1056\u002FNEJMoa0708857\nSotiropoulos, 2007, Transpl Int, 20, 141, 10.1111\u002Fj.1432-2277.2006.00412.x\nKlintmalm, 1998, Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome, Ann Surg, 228, 479, 10.1097\u002F00000658-199810000-00005\nMarubashi, 2006, Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation, Transplant Proc, 38, 3640, 10.1016\u002Fj.transproceed.2006.10.067\nSakata, 2008, Preoperative predictors of vascular invasion in hepatocellular carcinoma, Eur J Surg Oncol, 34, 900, 10.1016\u002Fj.ejso.2008.01.031\nLohe, 2007, Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation, Clin Transplant, 21, 696\nEsnaola, 2002, Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation, J Gastrointest Surg, 6, 224, 10.1016\u002FS1091-255X(01)00015-4\nDurazo, 2008, Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma, J Gastroenterol Hepatol, 23, 1541, 10.1111\u002Fj.1440-1746.2008.05395.x",{"EN":872},"Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma",{"VOID":874},"10.1111\u002Fj.1477-2574.2009.00128.x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X15302410",[877,892,904,916,931,943],{"id":878,"sortIndex":126,"researcher":17,"roles":879,"affiliations":880,"properties":889},"52812e12-7851-4cc3-8d24-03d1d4c9cbad",[128],[881],{"id":17,"sortIndex":121,"affiliation":882,"properties":17},{"id":883,"createTime":884,"updateTime":884,"relativeEntities":885,"slug":17,"properties":886,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"d15967ac-f4ec-436d-8e86-f0ec3d1a1434","2024-01-16T23:52:49.023+00:00",[],{"title":887},{"VI":888},"Transplant Center, University of Kentucky College of Medicine, Lexington, KY",{"title":890},{"VI":891},"Alvaro Koch",{"id":893,"sortIndex":156,"researcher":17,"roles":894,"affiliations":895,"properties":901},"93cc24cd-fc70-4b60-8a46-f98d8e8e5b92",[128],[896],{"id":17,"sortIndex":121,"affiliation":897,"properties":17},{"id":883,"createTime":884,"updateTime":884,"relativeEntities":898,"slug":17,"properties":899,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":900},{"VI":888},{"title":902},{"VI":903},"Roberto Gedaly",{"id":905,"sortIndex":18,"researcher":17,"roles":906,"affiliations":907,"properties":913},"c8e27cc5-6c5c-41a1-9bc5-984e91bb611a",[128],[908],{"id":17,"sortIndex":121,"affiliation":909,"properties":17},{"id":883,"createTime":884,"updateTime":884,"relativeEntities":910,"slug":17,"properties":911,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":912},{"VI":888},{"title":914},{"VI":915},"Dinesh Ranjan",{"id":917,"sortIndex":222,"researcher":17,"roles":918,"affiliations":919,"properties":928},"309fe4aa-3fe2-4909-bb23-a2a943897b39",[128],[920],{"id":17,"sortIndex":121,"affiliation":921,"properties":17},{"id":922,"createTime":923,"updateTime":923,"relativeEntities":924,"slug":17,"properties":925,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"44ce3f26-e93e-4f0e-ac5b-fc53fd2d8f01","2024-01-16T23:52:49.000+00:00",[],{"title":926},{"VI":927},"Transplantation Institute, Methodist Hospital, University of Tennessee Medical School, Memphis, TN, USA",{"title":929},{"VI":930},"Santiago Vera",{"id":932,"sortIndex":121,"researcher":17,"roles":933,"affiliations":934,"properties":940},"fa393fa9-411a-46f5-9275-cf8b1a958a8d",[128],[935],{"id":17,"sortIndex":121,"affiliation":936,"properties":17},{"id":883,"createTime":884,"updateTime":884,"relativeEntities":937,"slug":17,"properties":938,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":939},{"VI":888},{"title":941},{"VI":942},"Patrick P. McHugh",{"id":944,"sortIndex":143,"researcher":17,"roles":945,"affiliations":946,"properties":952},"705730ea-71d5-4b1a-bc7d-ae564c188766",[128],[947],{"id":17,"sortIndex":121,"affiliation":948,"properties":17},{"id":883,"createTime":884,"updateTime":884,"relativeEntities":949,"slug":17,"properties":950,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":951},{"VI":888},{"title":953},{"VI":954},"Jeffrey Gilbert",{"url":875,"publisher":956,"properties":978},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":957,"slug":10,"properties":958,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":961,"manageAffiliations":962,"indexDatabases":963,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":959,"title":960},{"VOID":13},{"EN":10},[],[],[964,971],{"id":82,"indexDatabase":965,"url":95,"indexYears":96,"academicFieldIds":970,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":966,"label":967,"description":968,"key":92,"publicationTags":969,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":972,"url":77,"indexYears":17,"academicFieldIds":977,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":973,"label":974,"description":975,"key":73,"publicationTags":976,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":979,"pages":981},{"VOID":980},"12",{"VOID":982},"56-61","2010-02-01",2010,{"id":986,"createTime":987,"updateTime":988,"relativeEntities":989,"slug":990,"properties":991,"entityType":118,"verifyStatus":119,"verifyTime":988,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":998,"fullTextUrl":17,"authors":999,"publicationType":245,"publisherRelationship":1102,"citationCount":17,"citationInfo":17,"publishDate":1130,"publishYear":1131,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"d56372a3-841d-424f-b071-84e150176e7c","2023-11-25T20:39:24.695+00:00","2025-02-18T23:51:54.462+00:00",[],"Interval-dynamics-of-transplantability-for-hepatocellular-carcinoma-after-primary-curative-resection-risk-factors-for-nontransplantable-recurrence",{"references":992,"title":994,"doi":996},{"VOID":993},"Llovet, 2021, Hepatocellular carcinoma, Nat Rev Dis Prim, 7, 6, 10.1038\u002Fs41572-020-00240-3\nCherqui, 2009, Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation, Ann Surg, 250, 738, 10.1097\u002FSLA.0b013e3181bd582b\nSapisochin, 2017, Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches, Nat Rev Gastroenterol Hepatol, 14, 203, 10.1038\u002Fnrgastro.2016.193\nOmata, 2017, Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update, Hepatol Int, 11, 317, 10.1007\u002Fs12072-017-9799-9\n2018, Electronic address eee, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 69, 182, 10.1016\u002Fj.jhep.2018.03.019\nMarrero, 2018, Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases, Hepatology, 68, 723, 10.1002\u002Fhep.29913\nMazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 334, 693, 10.1056\u002FNEJM199603143341104\nMazzaferro, 2018, Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma, Gastroenterology, 154, 128, 10.1053\u002Fj.gastro.2017.09.025\nGorgen, 2019, Patterns and predictors of mortality after waitlist dropout of patients with hepatocellular carcinoma awaiting liver transplantation, Transplantation, 103, 2136, 10.1097\u002FTP.0000000000002616\nToso, 2012, A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list, Hepatology, 56, 149, 10.1002\u002Fhep.25603\nGeissler, 2009, Immunosuppression for liver transplantation, Gut, 58, 452, 10.1136\u002Fgut.2008.163527\nThuluvath, 2021, Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases, J Hepatol, 75, 1434, 10.1016\u002Fj.jhep.2021.08.008\nPark, 2015, Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study, Liver Int, 35, 2155, 10.1111\u002Fliv.12818\nPoon, 2002, Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation, Ann Surg, 235, 373, 10.1097\u002F00000658-200203000-00009\nHo, 2016, Surgery for intermediate and advanced hepatocellular carcinoma: a consensus report from the 5th Asia-Pacific primary liver cancer expert meeting (APPLE 2014), Liver Cancer, 5, 245, 10.1159\u002F000449336\nMinagawa, 2022, Anatomic resection for hepatocellular carcinoma: prognostic impact assessed from recurrence treatment, Ann Surg Oncol, 29, 913, 10.1245\u002Fs10434-021-10380-9\nKim, 2020, Predicting hepatocellular carcinoma recurrence beyond Milan criteria after liver resection for solitary hepatocellular carcinoma, J Gastrointest Surg, 24, 2219, 10.1007\u002Fs11605-019-04363-1\nGelli, 2020, Liver resection for early hepatocellular carcinoma: preoperative predictors of non transplantable recurrence and implications for treatment allocation, Ann Surg, 272, 820, 10.1097\u002FSLA.0000000000004259\nZheng, 2017, Prediction of hepatocellular carcinoma recurrence beyond Milan criteria after resection: validation of a clinical risk score in an international cohort, Ann Surg, 266, 693, 10.1097\u002FSLA.0000000000002360\nTsilimigras, 2020, Recurrence patterns and outcomes after resection of hepatocellular carcinoma within and beyond the Barcelona clinic liver cancer criteria, Ann Surg Oncol, 27, 2321, 10.1245\u002Fs10434-020-08452-3\nHwang, 2007, Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma, Liver Transplant, 13, 741, 10.1002\u002Flt.21157\nBelghiti, 2003, Resection prior to liver transplantation for hepatocellular carcinoma, Ann Surg, 238, 885, 10.1097\u002F01.sla.0000098621.74851.65\nKim, 2008, Salvage liver transplantation for recurrent hepatocellular carcinoma after liver resection: feasibility of the Milan criteria and operative risk, Transplant Proc, 40, 3558, 10.1016\u002Fj.transproceed.2008.03.175\nHo, 2013, Analysis of the risk factors of untransplantable recurrence after primary curative resection for patients with hepatocellular carcinoma, Ann Surg Oncol, 20, 2526, 10.1245\u002Fs10434-013-2940-7\nYao, 2001, Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival, Hepatology, 33, 1394, 10.1053\u002Fjhep.2001.24563\nHo, 2009, Liver resection improves the survival of patients with multiple hepatocellular carcinomas, Ann Surg Oncol, 16, 848, 10.1245\u002Fs10434-008-0282-7\nDindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097\u002F01.sla.0000133083.54934.ae\nHong, 2017, Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma, Tumour Biol, 39, 10.1177\u002F1010428317720863\nHo, 2020, Survival after treatable hepatocellular carcinoma recurrence in liver recipients: a nationwide cohort analysis, Front Oncol, 10\nGroeschl, 2013, Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint, Ann Surg Oncol, 20, 3591, 10.1245\u002Fs10434-013-3031-5\nFine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, 94, 10.1080\u002F01621459.1999.10474144\nTabrizian, 2015, Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis, Ann Surg, 261, 947, 10.1097\u002FSLA.0000000000000710\nMehta, 2019, Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: implications for organ allocation, Am J Transplant, 19, 2210, 10.1111\u002Fajt.15353\nLai, 2021, Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant, JAMA Surg, 156, 10.1001\u002Fjamasurg.2021.3112\nDi Sandro, 2019, Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases, Updates Surg, 71, 285, 10.1007\u002Fs13304-019-00649-w\nTsilimigras, 2019, Prognosis after resection of Barcelona clinic liver cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification, Ann Surg Oncol, 26, 3693, 10.1245\u002Fs10434-019-07580-9\nFurukawa, 2017, Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona clinic liver cancer classification, J Hepatobiliary Pancreat Sci, 24, 199, 10.1002\u002Fjhbp.436\nIkegami, 2008, The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria, Transplantation, 86, 641, 10.1097\u002FTP.0b013e3181814de2\nKim, 2019, Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection, Int J Biol Markers, 34, 123, 10.1177\u002F1724600819834306\nErstad, 2019, Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma, Ann Surg Oncol, 26, 1474, 10.1245\u002Fs10434-019-07227-9\nNakagawa, 2021, Four gene intrahepatic metastasis-risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis, Surgery, 169, 903, 10.1016\u002Fj.surg.2020.09.032\nSugimachi, 2001, Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma, J Hepatobiliary Pancreat Surg, 8, 410, 10.1007\u002Fs005340100002\nLee, 2014, Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation, Liver Transplant, 20, 1057, 10.1002\u002Flt.23919\nSerenari, 2021, The Impact of time interval between hepatic resection and liver transplantation on clinical outcome in patients with hepatocellular carcinoma, Cancers, 13, 10.3390\u002Fcancers13102398\nBrown, 2019, Adjuvant treatment of hepatocellular carcinoma: prospect of immunotherapy, Hepatology, 70, 1437, 10.1002\u002Fhep.30633\nRodriguez-Peralvarez, 2013, A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability, Ann Surg Oncol, 20, 325, 10.1245\u002Fs10434-012-2513-1\nHalazun, 2017, Recurrence after liver transplantation for hepatocellular carcinoma: a new MORAL to the Story, Ann Surg, 265, 557, 10.1097\u002FSLA.0000000000001966\nWang, 2021, The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma, Sci Rep, 11, 2415, 10.1038\u002Fs41598-021-82058-x\nLee, 2021, Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation, Ann Surg, 273, 564, 10.1097\u002FSLA.0000000000003268\nLiu, 2021, Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals, Cancer Imag, 21, 56, 10.1186\u002Fs40644-021-00425-3\nPoon, 2000, Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis, J Clin Oncol, 18, 1094, 10.1200\u002FJCO.2000.18.5.1094\nYasuda, 2020, Liver regeneration after major liver resection for hepatocellular carcinoma in the elderly, J Invest Surg, 33, 332, 10.1080\u002F08941939.2018.1517839\nDahiya, 2010, Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience, Surgery, 147, 676, 10.1016\u002Fj.surg.2009.10.043\nVibert, 2020, Advances in resection and transplantation for hepatocellular carcinoma, J Hepatol, 72, 262, 10.1016\u002Fj.jhep.2019.11.017\nRuiz, 2021, Monosegment associating liver partition and portal vein ligation for staged hepatectomy: preserving segment 1 as the only liver remnant after hepatocellular carcinoma recurrence, Ann Hepatobiliary Pancreat Surg, 25, 562, 10.14701\u002Fahbps.2021.25.4.562\nSiriwardana, 2012, Role of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study, World J Surg, 36, 1640, 10.1007\u002Fs00268-012-1522-3\nAli, 2017, Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection, Eur J Nucl Med Mol Imag, 44, 2195, 10.1007\u002Fs00259-017-3792-3\nHasegawa, 2005, Prognostic impact of anatomic resection for hepatocellular carcinoma, Ann Surg, 242, 252, 10.1097\u002F01.sla.0000171307.37401.db\nAhn, 2013, A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function, Eur J Surg Oncol, 39, 964, 10.1016\u002Fj.ejso.2013.06.019\nHo, 2012, Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria, Ann Surg Oncol, 19, 826, 10.1245\u002Fs10434-011-1975-x\nChien, 2019, Taiwan consensus statement on the management of chronic hepatitis B, J Formos Med Assoc, 118, 7, 10.1016\u002Fj.jfma.2018.11.008\nChang, 2013, National antiviral treatment program and the incidence of hepatocellular carcinoma and associated mortality in Taiwan: a preliminary report, Med Care, 51, 908, 10.1097\u002FMLR.0b013e3182a502ba\nLiao, 2021, Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan, J Hepatol, 75, 132, 10.1016\u002Fj.jhep.2021.02.029\nChiang, 2015, Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan, Hepatology, 61, 1154, 10.1002\u002Fhep.27630\nGao, 2020, Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis, Eur J Gastroenterol Hepatol, 32, 1207, 10.1097\u002FMEG.0000000000001639\nZhang, 2015, Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma, World J Gastroenterol, 21, 3860, 10.3748\u002Fwjg.v21.i13.3860\nSingal, 2010, Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma, Aliment Pharmacol Ther, 32, 851, 10.1111\u002Fj.1365-2036.2010.04414.x\nIkeda, 2017, Direct-acting antivirals decreased tumor recurrence after initial treatment of hepatitis C virus-related hepatocellular carcinoma, Dig Dis Sci, 62, 2932, 10.1007\u002Fs10620-017-4739-z\nWang, 2020, Early and late recurrence of hepatitis B virus-associated hepatocellular carcinoma, Oncologist, 25, e1541, 10.1634\u002Ftheoncologist.2019-0944\nChiang, 2008, Focal gains of VEGFA and molecular classification of hepatocellular carcinoma, Cancer Res, 68, 6779, 10.1158\u002F0008-5472.CAN-08-0742\nDominguez, 2020, Impact of next-generation sequencing on outcomes in hepatocellular carcinoma: how precise are We really?, J Hepatocell Carcinoma, 7, 33, 10.2147\u002FJHC.S217948\nHarding, 2019, Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies, Clin Cancer Res, 25, 2116, 10.1158\u002F1078-0432.CCR-18-2293\nLlovet, 2018, Molecular therapies and precision medicine for hepatocellular carcinoma, Nat Rev Clin Oncol, 15, 599, 10.1038\u002Fs41571-018-0073-4\nDuvoux, 2012, Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria, Gastroenterology, 143, 986, 10.1053\u002Fj.gastro.2012.05.052",{"EN":995},"Interval dynamics of transplantability for hepatocellular carcinoma after primary curative resection: risk factors for nontransplantable recurrence",{"VOID":997},"10.1016\u002Fj.hpb.2022.10.010","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X22016355",[1000,1017,1029,1041,1053,1068,1080],{"id":1001,"sortIndex":126,"researcher":17,"roles":1002,"affiliations":1003,"properties":1014},"48ace73a-f467-4e48-875f-83f87001bc07",[128],[1004],{"id":17,"sortIndex":121,"affiliation":1005,"properties":17},{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1009,"slug":1010,"properties":1011,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"3f3df3af-5d01-4bb9-82d9-74c3246dcb7a","2023-12-24T05:40:08.702+00:00","2024-12-19T00:24:58.457+00:00",[],"Department-of-Surgery-National-Taiwan-University-Hospital-Taipei-Taiwan",{"title":1012},{"VI":1013},"Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan",{"title":1015},{"VI":1016},"Ming-Chih Ho",{"id":1018,"sortIndex":222,"researcher":17,"roles":1019,"affiliations":1020,"properties":1026},"ea8be29f-d12e-4557-a4df-10b4d0ae9391",[128],[1021],{"id":17,"sortIndex":121,"affiliation":1022,"properties":17},{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1023,"slug":1010,"properties":1024,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1025},{"VI":1013},{"title":1027},{"VI":1028},"Chih-Yang Hsiao",{"id":1030,"sortIndex":206,"researcher":17,"roles":1031,"affiliations":1032,"properties":1038},"9750d71a-5c51-44c0-9ddf-f0b91624d61a",[128],[1033],{"id":17,"sortIndex":121,"affiliation":1034,"properties":17},{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1035,"slug":1010,"properties":1036,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1037},{"VI":1013},{"title":1039},{"VI":1040},"Rey-Heng Hu",{"id":1042,"sortIndex":156,"researcher":17,"roles":1043,"affiliations":1044,"properties":1050},"1d7ec72e-0712-4435-84ce-c5503a254eb7",[128],[1045],{"id":17,"sortIndex":121,"affiliation":1046,"properties":17},{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1047,"slug":1010,"properties":1048,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1049},{"VI":1013},{"title":1051},{"VI":1052},"Po-Huang Lee",{"id":1054,"sortIndex":18,"researcher":17,"roles":1055,"affiliations":1056,"properties":1065},"a5fce306-6a49-4a99-af23-e0e8c6aa199a",[128],[1057],{"id":1058,"sortIndex":121,"affiliation":1059,"properties":1063},"da409190-3f07-4b5f-9ee2-168cd4d7b03d",{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1060,"slug":1010,"properties":1061,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1062},{"VI":1013},{"title":1064},{"VI":1013},{"title":1066},{"VI":1067},"Yao-Ming Wu",{"id":1069,"sortIndex":143,"researcher":17,"roles":1070,"affiliations":1071,"properties":1077},"6f75f437-ebf0-4390-80f4-74f6d63c3641",[128],[1072],{"id":17,"sortIndex":121,"affiliation":1073,"properties":17},{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1074,"slug":1010,"properties":1075,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1076},{"VI":1013},{"title":1078},{"VI":1079},"Cheng-Maw Ho",{"id":1081,"sortIndex":121,"researcher":17,"roles":1082,"affiliations":1083,"properties":1099},"4295d18a-a15a-49ea-8f77-2ad737fb1503",[128],[1084,1094],{"id":1085,"sortIndex":143,"affiliation":1086,"properties":1093},"514235f0-b62e-44f6-b1ad-51d46c5d36c1",{"id":1087,"createTime":1088,"updateTime":1088,"relativeEntities":1089,"slug":17,"properties":1090,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"13d296ea-69ef-4507-8f3f-e6f858b65ad3","2024-01-11T22:21:15.118+00:00",[],{"title":1091},{"VI":1092},"Department of Medicine, National Taiwan University Hospital Jinshan Branch, New Taipei City, Taiwan",{},{"id":17,"sortIndex":121,"affiliation":1095,"properties":17},{"id":1006,"createTime":1007,"updateTime":1008,"relativeEntities":1096,"slug":1010,"properties":1097,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1098},{"VI":1013},{"title":1100},{"VI":1101},"Hou-Ying Cheng",{"url":998,"publisher":1103,"properties":1125},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1104,"slug":10,"properties":1105,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":1108,"manageAffiliations":1109,"indexDatabases":1110,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":1106,"title":1107},{"VOID":13},{"EN":10},[],[],[1111,1118],{"id":82,"indexDatabase":1112,"url":95,"indexYears":96,"academicFieldIds":1117,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":1113,"label":1114,"description":1115,"key":92,"publicationTags":1116,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":1119,"url":77,"indexYears":17,"academicFieldIds":1124,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":1120,"label":1121,"description":1122,"key":73,"publicationTags":1123,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":1126,"pages":1128},{"VOID":1127},"25",{"VOID":1129},"218-228","2023-02-01",2023,{"id":1133,"createTime":1134,"updateTime":1135,"relativeEntities":1136,"slug":1137,"properties":1138,"entityType":118,"verifyStatus":119,"verifyTime":1135,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":1145,"fullTextUrl":17,"authors":1146,"publicationType":245,"publisherRelationship":1384,"citationCount":17,"citationInfo":17,"publishDate":1412,"publishYear":1413,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"1c3d34f3-eaff-4fb3-a19a-e2af98a75ba0","2024-01-16T13:08:40.335+00:00","2025-01-24T23:51:08.452+00:00",[],"Outcomes-of-extended-versus-limited-indications-for-patients-undergoing-a-liver-resection-for-colorectal-cancer-liver-metastases",{"references":1139,"title":1141,"doi":1143},{"VOID":1140},"Nordlinger, 1996, Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie, Cancer, 77, 1254, 10.1002\u002F(SICI)1097-0142(19960401)77:7\u003C1254::AID-CNCR5>3.0.CO;2-I\nFong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Ann Surg, 230, 309, 10.1097\u002F00000658-199909000-00004\nAltendorf-Hofmann, 2003, A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma, Surg Oncol Clin N Am, 12, 165, 10.1016\u002FS1055-3207(02)00091-1\nSharma, 2008, Management of hepatic metastasis from colorectal cancers: an update, J Hepatobiliary Pancreat Surg, 15, 570, 10.1007\u002Fs00534-008-1350-x\nPawlik, 2006, Debunking dogma: surgery for four or more colorectal liver metastases is justified, J Gastrointest Surg, 10, 240, 10.1016\u002Fj.gassur.2005.07.027\nMehrabi, 2008, Mesohepatectomy as an option for the treatment of central liver tumors, J Am Coll Surg, 207, 499, 10.1016\u002Fj.jamcollsurg.2008.05.024\nPulitano, 2011, Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis, Ann Surg Oncol, 18, 1380, 10.1245\u002Fs10434-010-1459-4\nFong, 1999, Surgical therapy of hepatic colorectal metastasis, CA Cancer J Clin, 49, 231, 10.3322\u002Fcanjclin.49.4.231\nPawlik, 2008, Expanding criteria for resectability of colorectal liver metastases, Oncologist, 13, 51, 10.1634\u002Ftheoncologist.2007-0142\nShimada, 2009, Treatment for colorectal liver metastases: a review, Langenbecks Arch Surg, 394, 973, 10.1007\u002Fs00423-009-0530-8\nAdam, 2000, Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors, Ann Surg, 232, 777, 10.1097\u002F00000658-200012000-00006\nGallagher, 2010, Metastatic colorectal cancer: from improved survival to potential cure, Oncology, 78, 237, 10.1159\u002F000315730\nYang, 2010, Extending limits of resection for metastatic colorectal cancer: risk benefit ratio, J Surg Oncol, 102, 996, 10.1002\u002Fjso.21701\nRazafindratsira, 2011, Complications of intraoperative radiofrequency ablation of liver metastases, HPB, 13, 15, 10.1111\u002Fj.1477-2574.2010.00243.x\nEvrard, 2012, Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection, Br J Surg, 99, 558, 10.1002\u002Fbjs.8665\nRuers, 2012, Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004), Ann Oncol, 23, 2619, 10.1093\u002Fannonc\u002Fmds053\nFolprecht, 2010, Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial, Lancet Oncol, 11, 38, 10.1016\u002FS1470-2045(09)70330-4\nLam, 2012, A systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases, Ann Surg Oncol, 19, 1292, 10.1245\u002Fs10434-011-2061-0\nStrasberg, 2005, Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system, J Hepatobiliary Pancreat Surg, 12, 351, 10.1007\u002Fs00534-005-0999-7\nvan de Poll, 2007, Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism, Am J Clin Nutr, 85, 167, 10.1093\u002Fajcn\u002F85.1.167\nvan Dam, 2008, Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection, Br J Surg, 95, 969, 10.1002\u002Fbjs.6227\nvan den Broek, 2011, Development of a composite endpoint for randomized controlled trials in liver surgery, Br J Surg, 98, 1138, 10.1002\u002Fbjs.7503\nMarang-van de Mheen, 2006, Adverse outcomes in surgical patients: implementation of a nationwide reporting system, Qual Saf Health Care, 15, 320, 10.1136\u002Fqshc.2005.016220\nDindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097\u002F01.sla.0000133083.54934.ae\nde Haas, 2011, Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection, Ann Surg, 253, 1069, 10.1097\u002FSLA.0b013e318217e898\nPawlik, 2005, Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases, Ann Surg, 241, 715, 10.1097\u002F01.sla.0000160703.75808.7d\nde Jong, 2009, Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients, Ann Surg, 250, 440, 10.1097\u002FSLA.0b013e3181b4539b\nKanas, 2012, Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors, Clin Epidemiol, 4, 283\nSaltz, 2008, Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study, J Clin Oncol, 26, 2013, 10.1200\u002FJCO.2007.14.9930\nvan Iersel, 2010, Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy, Ann Oncol, 21, 1662, 10.1093\u002Fannonc\u002Fmdp589\nCassidy, 2011, XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results, Br J Cancer, 105, 58, 10.1038\u002Fbjc.2011.201\nMaughan, 2011, Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial, Lancet, 377, 2103, 10.1016\u002FS0140-6736(11)60613-2\nWiering, 2011, Long-term global quality of life in patients treated for colorectal liver metastases, Br J Surg, 98, 565, 10.1002\u002Fbjs.7365\nLangenhoff, 2006, Quality of life after surgical treatment of colorectal liver metastases, Br J Surg, 93, 1007, 10.1002\u002Fbjs.5387\nFarges, 2012, Incidence and risks of liver resection: an all-inclusive French nationwide study, Ann Surg, 256, 697, 10.1097\u002FSLA.0b013e31827241d5\nSchiesser, 2008, Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases, J Gastrointest Surg, 12, 1054, 10.1007\u002Fs11605-007-0438-y\nAbbott, 2013, Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study, Ann Surg Oncol, 20, 139, 10.1245\u002Fs10434-012-2515-z\nVente, 2009, Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis, Eur Radiol, 19, 951, 10.1007\u002Fs00330-008-1211-7\nSchnitzbauer, 2012, Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings, Ann Surg, 255, 405, 10.1097\u002FSLA.0b013e31824856f5\nKnoefel, 2013, In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection, Br J Surg, 100, 388, 10.1002\u002Fbjs.8955\nNeumann, 2013, Split decision, Br J Surg, 100, 310, 10.1002\u002Fbjs.9050",{"EN":1142},"Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases",{"VOID":1144},"10.1111\u002Fhpb.12181","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X15315975",[1147,1174,1198,1227,1246,1262,1281,1314,1329,1348],{"id":1148,"sortIndex":181,"researcher":17,"roles":1149,"affiliations":1150,"properties":1171},"de055449-a0a8-4600-b685-c0b628c827a3",[128],[1151,1163],{"id":1152,"sortIndex":143,"affiliation":1153,"properties":1162},"22d53071-0641-4576-95e5-bf2d8c0f2f26",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1157,"slug":1158,"properties":1159,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"007db061-b09f-4f06-8e4a-7548ad29abe6","2024-01-16T13:08:40.399+00:00","2025-06-11T13:59:21.708+00:00",[],"Euregional-Surgical-HPB-collaboration-Aachen-Maastricht-Germany-The-Netherlands",{"title":1160},{"VI":1161},"Euregional Surgical HPB collaboration Aachen-Maastricht, Germany–The Netherlands",{},{"id":17,"sortIndex":121,"affiliation":1164,"properties":17},{"id":1165,"createTime":1166,"updateTime":1166,"relativeEntities":1167,"slug":17,"properties":1168,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"dfb784f0-365c-4e98-9a9e-1784980bef47","2024-01-16T13:08:40.375+00:00",[],{"title":1169},{"VI":1170},"Department of General, Visceral and Transplant Surgery, University Hospital RWTH Aachen, Aachen, Germany",{"title":1172},{"VI":1173},"Ulf P. Neumann",{"id":1175,"sortIndex":121,"researcher":17,"roles":1176,"affiliations":1177,"properties":1195},"cb2be193-3fb9-46c5-9413-d18a52f8d7b1",[128],[1178,1185],{"id":1179,"sortIndex":143,"affiliation":1180,"properties":1184},"65ec49cf-b3ba-4f90-9d8c-de97a97d55a4",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1181,"slug":1158,"properties":1182,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1183},{"VI":1161},{},{"id":17,"sortIndex":121,"affiliation":1186,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1190,"slug":1191,"properties":1192,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"803093b2-ffb3-4a4d-ac38-d225119a3d5a","2023-12-13T12:37:22.450+00:00","2024-10-05T10:12:36.320+00:00",[],"Department-of-Surgery-Maastricht-University-Medical-Centre-Maastricht-The-Netherlands",{"title":1193},{"VI":1194},"Department of Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands",{"title":1196},{"VI":1197},"Ronald M. van Dam",{"id":1199,"sortIndex":499,"researcher":17,"roles":1200,"affiliations":1201,"properties":1224},"d867f724-0792-44d9-b32f-69e19e9b70eb",[128],[1202,1209,1214],{"id":1203,"sortIndex":222,"affiliation":1204,"properties":1208},"b2a27ed3-3293-41f4-8a6d-f3ec5b9209ee",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1205,"slug":1158,"properties":1206,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1207},{"VI":1161},{},{"id":17,"sortIndex":121,"affiliation":1210,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1211,"slug":1191,"properties":1212,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1213},{"VI":1194},{"id":1215,"sortIndex":143,"affiliation":1216,"properties":1223},"bdf42982-6c3a-468a-8fde-3ad2a47325d2",{"id":1217,"createTime":1218,"updateTime":1218,"relativeEntities":1219,"slug":17,"properties":1220,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"6d68749c-d271-4678-9a37-410d50198c72","2023-12-09T15:57:51.564+00:00",[],{"title":1221},{"VI":1222},"Nutrim School for Nutrition, Toxicology and Metabolism, Maastricht University, Maastricht, The Netherlands",{},{"title":1225},{"VI":1226},"Cornelis H.C. Dejong",{"id":1228,"sortIndex":126,"researcher":17,"roles":1229,"affiliations":1230,"properties":1243},"acc07da4-c8ad-43b5-b2d4-556bba4383db",[128],[1231,1238],{"id":1232,"sortIndex":143,"affiliation":1233,"properties":1237},"ad0a9c86-9a22-4215-956f-2374f8866ebc",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1234,"slug":1158,"properties":1235,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1236},{"VI":1161},{},{"id":17,"sortIndex":121,"affiliation":1239,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1240,"slug":1191,"properties":1241,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1242},{"VI":1194},{"title":1244},{"VI":1245},"Mechteld C. de Jong",{"id":1247,"sortIndex":18,"researcher":17,"roles":1248,"affiliations":1249,"properties":1259},"67158134-c1ee-4cb4-b289-55cc6c5e7f8b",[128],[1250],{"id":17,"sortIndex":121,"affiliation":1251,"properties":17},{"id":1252,"createTime":1253,"updateTime":1253,"relativeEntities":1254,"slug":1255,"properties":1256,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"bfb81ae8-85f2-430c-a4e9-1d60d17beb1d","2024-04-16T13:57:58.310+00:00",[],"Department-of-Surgery-Atrium-Medical-Center-Heerlen-The-Netherlands",{"title":1257},{"EN":1258},"Department of Surgery, Atrium Medical Center, Heerlen, The Netherlands",{"title":1260},{"VI":1261},"Jan Willem Greve",{"id":1263,"sortIndex":206,"researcher":17,"roles":1264,"affiliations":1265,"properties":1278},"73885868-4179-48da-98bd-19c02af6e192",[128],[1266,1273],{"id":1267,"sortIndex":143,"affiliation":1268,"properties":1272},"7deee89d-05eb-4f54-8029-5b9116ae6167",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1269,"slug":1158,"properties":1270,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1271},{"VI":1161},{},{"id":17,"sortIndex":121,"affiliation":1274,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1275,"slug":1191,"properties":1276,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1277},{"VI":1194},{"title":1279},{"VI":1280},"Marc H.A. Bemelmans",{"id":1282,"sortIndex":143,"researcher":17,"roles":1283,"affiliations":1284,"properties":1311},"3961c3d1-848b-4725-8df7-f0520dd9ca25",[128],[1285,1292,1297,1304],{"id":1286,"sortIndex":126,"affiliation":1287,"properties":1291},"80931d10-1e51-4ab7-af79-345bb775e03d",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1288,"slug":1158,"properties":1289,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1290},{"VI":1161},{},{"id":17,"sortIndex":121,"affiliation":1293,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1294,"slug":1191,"properties":1295,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1296},{"VI":1194},{"id":1298,"sortIndex":143,"affiliation":1299,"properties":1303},"dbb140de-e77c-4190-9d69-6de29a56b4c2",{"id":1217,"createTime":1218,"updateTime":1218,"relativeEntities":1300,"slug":17,"properties":1301,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1302},{"VI":1222},{},{"id":1305,"sortIndex":222,"affiliation":1306,"properties":1310},"ddae4a01-b445-407f-95ad-85ec74cc077e",{"id":1165,"createTime":1166,"updateTime":1166,"relativeEntities":1307,"slug":17,"properties":1308,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1309},{"VI":1170},{},{"title":1312},{"VI":1313},"Toine M. Lodewick",{"id":1315,"sortIndex":156,"researcher":17,"roles":1316,"affiliations":1317,"properties":1326},"aee1ec6f-373c-4a94-8ef4-a80b72db2204",[128],[1318],{"id":17,"sortIndex":121,"affiliation":1319,"properties":17},{"id":1320,"createTime":1321,"updateTime":1321,"relativeEntities":1322,"slug":17,"properties":1323,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"67168a6e-275c-4700-b060-771278ce96bb","2023-12-25T20:01:52.053+00:00",[],{"title":1324},{"VI":1325},"Department of Medical Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands",{"title":1327},{"VI":1328},"Rob L.H. Jansen",{"id":1330,"sortIndex":222,"researcher":17,"roles":1331,"affiliations":1332,"properties":1345},"0d597211-4b74-415e-84d2-1afa62ca4128",[128],[1333,1338],{"id":17,"sortIndex":121,"affiliation":1334,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1335,"slug":1191,"properties":1336,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1337},{"VI":1194},{"id":1339,"sortIndex":143,"affiliation":1340,"properties":1344},"920244bb-5458-4c2c-93f5-6dd964457a60",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1341,"slug":1158,"properties":1342,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1343},{"VI":1161},{},{"title":1346},{"VI":1347},"Maartje A.J. van den Broek",{"id":1349,"sortIndex":58,"researcher":17,"roles":1350,"affiliations":1351,"properties":1381},"6fd1c4a2-94e3-4f1c-80af-0445138c00a3",[128],[1352,1359,1364,1371],{"id":1353,"sortIndex":126,"affiliation":1354,"properties":1358},"db113067-f29c-4f8a-910a-f04530e74ad2",{"id":1154,"createTime":1155,"updateTime":1156,"relativeEntities":1355,"slug":1158,"properties":1356,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1357},{"VI":1161},{},{"id":17,"sortIndex":121,"affiliation":1360,"properties":17},{"id":1187,"createTime":1188,"updateTime":1189,"relativeEntities":1361,"slug":1191,"properties":1362,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1363},{"VI":1194},{"id":1365,"sortIndex":143,"affiliation":1366,"properties":1370},"d85438c7-4dd8-463c-94e2-29114f00b2f3",{"id":1217,"createTime":1218,"updateTime":1218,"relativeEntities":1367,"slug":17,"properties":1368,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1369},{"VI":1222},{},{"id":1372,"sortIndex":222,"affiliation":1373,"properties":1380},"4717d3de-efc3-4802-ba52-d076d4263137",{"id":1374,"createTime":1375,"updateTime":1375,"relativeEntities":1376,"slug":17,"properties":1377,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"30e034df-8797-479d-8d35-16cebc96f8f7","2024-01-16T13:08:40.498+00:00",[],{"title":1378},{"VI":1379},"Department of HPB Surgery and Liver Transplantation, Royal Free Hospital- University College London, London, UK",{},{"title":1382},{"VI":1383},"Steven W.M. Olde Damink",{"url":1145,"publisher":1385,"properties":1407},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1386,"slug":10,"properties":1387,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":1390,"manageAffiliations":1391,"indexDatabases":1392,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":1388,"title":1389},{"VOID":13},{"EN":10},[],[],[1393,1400],{"id":82,"indexDatabase":1394,"url":95,"indexYears":96,"academicFieldIds":1399,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":1395,"label":1396,"description":1397,"key":92,"publicationTags":1398,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":1401,"url":77,"indexYears":17,"academicFieldIds":1406,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":1402,"label":1403,"description":1404,"key":73,"publicationTags":1405,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":1408,"pages":1410},{"VOID":1409},"16",{"VOID":1411},"550-559","2014-06-01",2014,{"id":1415,"createTime":1416,"updateTime":1417,"relativeEntities":1418,"slug":1419,"properties":1420,"entityType":118,"verifyStatus":119,"verifyTime":1417,"verifyNote":120,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":1427,"fullTextUrl":17,"authors":1428,"publicationType":245,"publisherRelationship":1545,"citationCount":17,"citationInfo":17,"publishDate":1573,"publishYear":1574,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"2e8ad3a0-d06e-4913-8e37-f84ef786be37","2023-11-25T13:20:52.914+00:00","2024-12-23T23:50:13.551+00:00",[],"Additional-value-of-gadoxetic-acid-enhanced-MRI-to-conventional-extracellular-gadolinium-enhanced-MRI-for-the-surgical-management-of-colorectal-and-neuroendocrine-liver-metastases",{"references":1421,"title":1423,"doi":1425},{"VOID":1422},"Schiergens, 2017, Multidisciplinary treatment of colorectal liver metastases, Minerva Med, 10.23736\u002FS0026-4806.17.05371-X\nAraujo, 2015, Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis, Ann Surg Oncol, 10.1245\u002Fs10434-014-4354-6\nMakowiec, 2018, Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy, Int J Colorectal Dis, 10.1007\u002Fs00384-017-2916-3\nOmichi, 2018, Liver resection is justified for patients with bilateral multiple colorectal liver metastases: a propensity-score-matched analysis, Eur J Surg Oncol, 10.1016\u002Fj.ejso.2017.11.006\nPawlik, 2006, Debunking dogma: surgery for four or more colorectal liver metastases is justified, J Gastrointest Surg, 10, 240, 10.1016\u002Fj.gassur.2005.07.027\nAbdalla, 2004, Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\u002Fablation for colorectal liver metastases, Ann Surg, 239, 818, 10.1097\u002F01.sla.0000128305.90650.71\nWang, 2017, Long-term postoperative survival prediction in patients with colorectal liver metastasis, Oncotarget, 8, 79927, 10.18632\u002Foncotarget.20322\nChoti, 2002, Trends in long-term survival following liver resection for hepatic colorectal metastases, Ann Surg, 235, 759, 10.1097\u002F00000658-200206000-00002\nSahani, 2014, Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma, Ann Surg, 259, 861, 10.1097\u002FSLA.0000000000000525\nBenson, 2013, Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines, J Natl Compr Cancer Netw, 11, 141, 10.6004\u002Fjnccn.2013.0022\nBajpai, 2009, Recent progress in imaging of colorectal cancer liver metastases, Current Colorectal Cancer Rep, 5, 99, 10.1007\u002Fs11888-009-0015-8\nBipat, 2005, Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis, Radiology, 237, 123, 10.1148\u002Fradiol.2371042060\nChen, 2012, Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases, PLoS One, 7, e48681, 10.1371\u002Fjournal.pone.0048681\nFloriani, 2010, Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis, Int J Magn Reson Imaging, 31, 19, 10.1002\u002Fjmri.22010\nNiekel, 2010, Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and\u002For FDG PET\u002FCT: a meta-analysis of prospective studies including patients who have not previously undergone treatment, Radiology, 257, 674, 10.1148\u002Fradiol.10100729\nWiering, 2005, The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases, Cancer, 104, 2658, 10.1002\u002Fcncr.21569\nKoh, 2012, Liver-specific contrast agents, Cancer Imaging, 12, 363, 10.1102\u002F1470-7330.2012.9022\nVan Beers, 2012, Primovist, eovist: what to expect?, J Hepatol, 57, 421, 10.1016\u002Fj.jhep.2012.01.031\nHuppertz, 2004, Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings, Radiology, 230, 266, 10.1148\u002Fradiol.2301020269\nThompson, 2008, Contrast agent approved for liver imaging, Am J Health Syst Pharm, 65, 1490\nJhaveri, 2015, Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid), Am J Roentgenol, 204, 498, 10.2214\u002FAJR.13.12399\nVreugdenburg, 2016, Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis, Int J Colorectal Dis, 31, 1739, 10.1007\u002Fs00384-016-2664-9\nCho, 2015, Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer, World J Surg, 39, 1161, 10.1007\u002Fs00268-015-2944-5\nKim, 2014, Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques, Radiology, 274, 712, 10.1148\u002Fradiol.14140390\nMuhi, 2011, Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI, J Magn Reson Imaging, 34, 326, 10.1002\u002Fjmri.22613\nZech, 2014, Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases, Br J Surg, 101, 622\nHammerstingl, 2002, Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient, Acad Radiol, 9, S119, 10.1016\u002FS1076-6332(03)80415-4\nBeets-Tan, 2014, Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases, Br J Surg, 101, 613, 10.1002\u002Fbjs.9465\nMaher, 2017, The management of colorectal liver metastases, Clin Radiol, 72, 617, 10.1016\u002Fj.crad.2017.05.016\nSmith, 2009, Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases, Br J Surg, 96, 1101, 10.1002\u002Fbjs.6735\nSofue, 2014, Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?, Eur Radiol, 24, 2532, 10.1007\u002Fs00330-014-3233-7",{"EN":1424},"Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases",{"VOID":1426},"10.1016\u002Fj.hpb.2019.09.009","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X1930721X",[1429,1445,1457,1469,1485,1497,1509,1521,1533],{"id":1430,"sortIndex":181,"researcher":17,"roles":1431,"affiliations":1432,"properties":1442},"3c82e391-2e55-4ca4-9c54-41360c9e6b2d",[128],[1433],{"id":17,"sortIndex":121,"affiliation":1434,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1437,"slug":1438,"properties":1439,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"a5e20ff7-9979-4105-95fa-e44f470f1c4d","2023-11-25T13:20:52.935+00:00",[],"CHU-de-Qu%C3%A9bec-Universit%C3%A9-Laval-11-C%C3%B4te-du-Palais-Quebec-G1R-2J6-QC-Canada",{"title":1440},{"VI":1441},"CHU de Québec – Université Laval, 11 Côte du Palais, Quebec, G1R 2J6 QC, Canada",{"title":1443},{"VI":1444},"Julie Marceau",{"id":1446,"sortIndex":222,"researcher":17,"roles":1447,"affiliations":1448,"properties":1454},"0d8c8069-383d-4da9-837c-7c6e6255ff94",[128],[1449],{"id":17,"sortIndex":121,"affiliation":1450,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1451,"slug":1438,"properties":1452,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1453},{"VI":1441},{"title":1455},{"VI":1456},"Carl Daigle",{"id":1458,"sortIndex":143,"researcher":17,"roles":1459,"affiliations":1460,"properties":1466},"4de1665b-8f51-4ec8-ae9a-2c91dde29208",[128],[1461],{"id":17,"sortIndex":121,"affiliation":1462,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1463,"slug":1438,"properties":1464,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1465},{"VI":1441},{"title":1467},{"VI":1468},"Sebastien Drolet",{"id":1470,"sortIndex":206,"researcher":17,"roles":1471,"affiliations":1472,"properties":1482},"e66dbf24-4ecd-4c52-8551-abe9313b739b",[128],[1473],{"id":17,"sortIndex":121,"affiliation":1474,"properties":17},{"id":1475,"createTime":1476,"updateTime":1476,"relativeEntities":1477,"slug":1478,"properties":1479,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"eaf8cd31-5846-4e84-acab-1a4d426f0697","2023-11-25T13:20:52.958+00:00",[],"Foothills-Medical-Centre-University-of-Calgary-1403-29-St-NW-Calgary-T2N-2T9-Alberta-Canada",{"title":1480},{"VI":1481},"Foothills Medical Centre – University of Calgary, 1403 29 St NW, Calgary, T2N 2T9 Alberta, Canada",{"title":1483},{"VI":1484},"Elijah Dixon",{"id":1486,"sortIndex":58,"researcher":17,"roles":1487,"affiliations":1488,"properties":1494},"3b339581-805c-451a-a774-18efe4fce2f1",[128],[1489],{"id":17,"sortIndex":121,"affiliation":1490,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1491,"slug":1438,"properties":1492,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1493},{"VI":1441},{"title":1495},{"VI":1496},"Jean-Francois B. Ouellet",{"id":1498,"sortIndex":121,"researcher":17,"roles":1499,"affiliations":1500,"properties":1506},"fc07f22c-b7b5-480e-b4da-28f441152816",[128],[1501],{"id":17,"sortIndex":121,"affiliation":1502,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1503,"slug":1438,"properties":1504,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1505},{"VI":1441},{"title":1507},{"VI":1508},"Claudya Morin",{"id":1510,"sortIndex":126,"researcher":17,"roles":1511,"affiliations":1512,"properties":1518},"e6296358-b3e8-4e61-b76b-ae60cd424bd6",[128],[1513],{"id":17,"sortIndex":121,"affiliation":1514,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1515,"slug":1438,"properties":1516,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1517},{"VI":1441},{"title":1519},{"VI":1520},"Isabelle Deshaies",{"id":1522,"sortIndex":156,"researcher":17,"roles":1523,"affiliations":1524,"properties":1530},"5e6a0b36-cac5-4723-8242-1cd010390bab",[128],[1525],{"id":17,"sortIndex":121,"affiliation":1526,"properties":17},{"id":1475,"createTime":1476,"updateTime":1476,"relativeEntities":1527,"slug":1478,"properties":1528,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1529},{"VI":1481},{"title":1531},{"VI":1532},"Chad G. Ball",{"id":1534,"sortIndex":18,"researcher":17,"roles":1535,"affiliations":1536,"properties":1542},"f0b855c4-2086-4e09-aabb-93033234835f",[128],[1537],{"id":17,"sortIndex":121,"affiliation":1538,"properties":17},{"id":1435,"createTime":1436,"updateTime":1436,"relativeEntities":1539,"slug":1438,"properties":1540,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1541},{"VI":1441},{"title":1543},{"VI":1544},"Jean-Francois Ouellet",{"url":1427,"publisher":1546,"properties":1568},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1547,"slug":10,"properties":1548,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":1551,"manageAffiliations":1552,"indexDatabases":1553,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":1549,"title":1550},{"VOID":13},{"EN":10},[],[],[1554,1561],{"id":82,"indexDatabase":1555,"url":95,"indexYears":96,"academicFieldIds":1560,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":1556,"label":1557,"description":1558,"key":92,"publicationTags":1559,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":1562,"url":77,"indexYears":17,"academicFieldIds":1567,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":1563,"label":1564,"description":1565,"key":73,"publicationTags":1566,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":1569,"pages":1571},{"VOID":1570},"22",{"VOID":1572},"710-715","2020-05-01",2020,{"id":1576,"createTime":1577,"updateTime":1577,"relativeEntities":1578,"slug":1579,"properties":1580,"entityType":118,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121,"primaryUrl":1587,"fullTextUrl":17,"authors":1588,"publicationType":245,"publisherRelationship":1679,"citationCount":17,"citationInfo":17,"publishDate":1707,"publishYear":1708,"citationAnalyzeStatus":16,"lastCitationAnalyze":17,"indexDatabases":17,"openAccess":17,"references":17,"isForceReanalyzing":276},"ef4bcb81-bfb5-4623-bfb1-1ba8cc8d18b1","2023-11-26T23:49:27.269+00:00",[],"-Idealized-vs-True-learning-curves-the-case-of-laparoscopic-liver-resection",{"references":1581,"title":1583,"doi":1585},{"VOID":1582},"Gagner, 1992, Laparoscopic partial hepatectomy for liver tumor, Surg Endosc, 6, 99\nTwaij, 2014, Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis, World J Gastroenterol, 20, 8274, 10.3748\u002Fwjg.v20.i25.8274\nCherqui, 2006, Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives, Ann Surg, 243, 499, 10.1097\u002F01.sla.0000206017.29651.99\nKazaryan, 2010, Laparoscopic resection of colorectal liver metastases: surgical and long-term oncologic outcome, Ann Surg, 252, 1005, 10.1097\u002FSLA.0b013e3181f66954\nNguyen, 2009, World review of laparoscopic liver resection-2,804 patients, Ann Surg, 250, 831, 10.1097\u002FSLA.0b013e3181b0c4df\nNguyen, 2009, Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes, Ann Surg, 250, 842, 10.1097\u002FSLA.0b013e3181bc789c\nMemeo, 2014, Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study, World J Surg, 38, 2919, 10.1007\u002Fs00268-014-2659-z\nSchiffman, 2014, Laparoscopic versus open liver resection for metastatic colorectal cancer: a metaanalysis of 610 patients, Surgery, 157, 211, 10.1016\u002Fj.surg.2014.08.036\nIshizawa, 2012, Laparoscopic segmentectomy of the liver: from segment I to VIII, Ann Surg, 256, 959, 10.1097\u002FSLA.0b013e31825ffed3\nTekkis, 2005, Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections, Ann Surg, 242, 83, 10.1097\u002F01.sla.0000167857.14690.68\nHopper, 2007, Learning curves in surgical practice, Postgrad Med J, 83, 777, 10.1136\u002Fpgmj.2007.057190\nMaruthappu, 2015, Surgical learning curves and operative efficiency: a cross-specialty observational study, BMJ Open, 5, e006679, 10.1136\u002Fbmjopen-2014-006679\nValerdi, 2011, 3\nRose, 2004, The machinist's learning curve, T & P Tool Prod, 70, 12\nBadiru, 2012, Half-Life Learn Curves Def Acquis Life Cycle Def Acquis Rev J, 19, 283\nVigano, 2009, The learning curve in laparoscopic liver resection: improved feasibility and reproducibility, Ann Surg, 250, 772, 10.1097\u002FSLA.0b013e3181bd93b2\nCai, 2014, Laparoscopic liver resection and the learning curve: a 14-year, single-center experience, Surg Endosc, 28, 1334, 10.1007\u002Fs00464-013-3333-5\nChan, 2014, Laparoscopic liver resection: lessons learnt after 100 cases, Hong Kong Med J, 20, 386\nSpampinato, 2015, Assessing the learning curve for totally laparoscopic major-complex liver resections: a single hepatobiliary surgeon experience, Surg Laparosc Endosc Percutan Tech, 25, e45, 10.1097\u002FSLE.0000000000000037\nDindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097\u002F01.sla.0000133083.54934.ae\nReddy, 2011, A standard definition of major hepatectomy: resection of four or more liver segments, HPB (Oxford), 13, 494, 10.1111\u002Fj.1477-2574.2011.00330.x\nCharlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016\u002F0021-9681(87)90171-8\nBiertho, 2003, Laparoscopic hepatectomy, 249\nHan, 2009, Techniques for performing laparoscopic liver resection in various hepatic locations, J Hepatobiliary Pancreat Surg, 16, 427, 10.1007\u002Fs00534-009-0118-2\nSchonland, 2014\nMoon, 2015, Lessons learned from a comparative analysis of surgical outcomes of and learning curves for laparoscopy-assisted distal gastrectomy, J Gastric Cancer, 15, 29, 10.5230\u002Fjgc.2015.15.1.29\nCoe, 2015, Outcomes improvement is not continuous along the learning curve for pancreaticoduodenectomy at the hospital level, J Gastrointest Surg, 19, 2132, 10.1007\u002Fs11605-015-2967-0\nFairhurst, 2011, The LapSim virtual reality simulator: promising but not yet proven, Surg Endosc, 25, 343, 10.1007\u002Fs00464-010-1181-0\nFrezza, 2006, A proposed canine model of laparoscopic nonanatomic liver resection, J Laparoendosc Adv Surg Tech A, 16, 15, 10.1089\u002Flap.2006.16.15\nMachado, 2004, A canine model of laparoscopic segmental liver resection, J Laparoendosc Adv Surg Tech A, 14, 325, 10.1089\u002Flap.2004.14.325\nWhite, 2014, A cadaver lab training facility to facilitate laparoscopic liver resection, Surg Laparosc Endosc Percutan Tech, 24, 357, 10.1097\u002FSLE.0000000000000046",{"EN":1584},"“Idealized” vs. “True” learning curves: the case of laparoscopic liver resection",{"VOID":1586},"10.1016\u002Fj.hpb.2016.03.610","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1365182X1631632X",[1589,1606,1618,1643,1655,1667],{"id":1590,"sortIndex":222,"researcher":17,"roles":1591,"affiliations":1592,"properties":1603},"32af8bc2-b624-4b30-adf2-7a83368a9c72",[128],[1593],{"id":17,"sortIndex":121,"affiliation":1594,"properties":17},{"id":1595,"createTime":1596,"updateTime":1597,"relativeEntities":1598,"slug":1599,"properties":1600,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"ab987e85-8190-4e9b-8da8-29a6aa391f1a","2024-01-14T21:37:01.617+00:00","2024-09-22T13:49:29.342+00:00",[],"Department-of-Surgery-Massachusetts-General-Hospital-Boston-MA-United-States",{"title":1601},{"VI":1602},"Department of Surgery, Massachusetts General Hospital, Boston, MA, United States",{"title":1604},{"VI":1605},"Radbeh Torabi",{"id":1607,"sortIndex":156,"researcher":17,"roles":1608,"affiliations":1609,"properties":1615},"d7ffc501-dd4c-488e-98de-4543af0a5b99",[128],[1610],{"id":17,"sortIndex":121,"affiliation":1611,"properties":17},{"id":1595,"createTime":1596,"updateTime":1597,"relativeEntities":1612,"slug":1599,"properties":1613,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1614},{"VI":1602},{"title":1616},{"VI":1617},"Cristina R. Ferrone",{"id":1619,"sortIndex":18,"researcher":17,"roles":1620,"affiliations":1621,"properties":1640},"ac6264e9-bac3-4bf5-a818-6f66f2f20373",[128],[1622,1635],{"id":1623,"sortIndex":143,"affiliation":1624,"properties":1632},"4ea766e0-6e89-4012-bbe6-5a3b127f7340",{"id":1625,"createTime":1626,"updateTime":1626,"relativeEntities":1627,"slug":1628,"properties":1629,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},"b8666708-3ab8-471b-aee1-efdd0fad7b70","2024-09-02T06:59:40.912+00:00",[],"Codman-Center-for-Clinical-Effectiveness-in-Surgery-Massachusetts-General-Hospital-Boston-MA-USA",{"title":1630},{"EN":1631},"Codman Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital, Boston, MA, USA",{"title":1633},{"VI":1634},"Codman Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital, Boston, MA, United States",{"id":17,"sortIndex":121,"affiliation":1636,"properties":17},{"id":1595,"createTime":1596,"updateTime":1597,"relativeEntities":1637,"slug":1599,"properties":1638,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1639},{"VI":1602},{"title":1641},{"VI":1642},"David C. Chang",{"id":1644,"sortIndex":126,"researcher":17,"roles":1645,"affiliations":1646,"properties":1652},"70652920-ea8b-4350-a360-4696367274a2",[128],[1647],{"id":17,"sortIndex":121,"affiliation":1648,"properties":17},{"id":1595,"createTime":1596,"updateTime":1597,"relativeEntities":1649,"slug":1599,"properties":1650,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1651},{"VI":1602},{"title":1653},{"VI":1654},"Francesco Sabbatino",{"id":1656,"sortIndex":121,"researcher":17,"roles":1657,"affiliations":1658,"properties":1664},"4536ad1c-8fdd-4454-a902-1900b9190541",[128],[1659],{"id":17,"sortIndex":121,"affiliation":1660,"properties":17},{"id":1595,"createTime":1596,"updateTime":1597,"relativeEntities":1661,"slug":1599,"properties":1662,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1663},{"VI":1602},{"title":1665},{"VI":1666},"Vincenzo Villani",{"id":1668,"sortIndex":143,"researcher":17,"roles":1669,"affiliations":1670,"properties":1676},"e650a4dd-773e-44a4-840b-c65a5ab3fe92",[128],[1671],{"id":17,"sortIndex":121,"affiliation":1672,"properties":17},{"id":1595,"createTime":1596,"updateTime":1597,"relativeEntities":1673,"slug":1599,"properties":1674,"entityType":46,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":121},[],{"title":1675},{"VI":1602},{"title":1677},{"VI":1678},"Jordan D. Bohnen",{"url":1587,"publisher":1680,"properties":1702},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1681,"slug":10,"properties":1682,"entityType":15,"verifyStatus":16,"verifyTime":17,"verifyNote":17,"syncStatus":16,"languages":17,"translateLanguages":17,"viewCount":18,"subjectFields":1685,"manageAffiliations":1686,"indexDatabases":1687,"url":17,"thumbnailPath":17,"statistic":17,"gsStatistic":17,"type":17,"analyzePriority":17},[],{"issn":1683,"title":1684},{"VOID":13},{"EN":10},[],[],[1688,1695],{"id":82,"indexDatabase":1689,"url":95,"indexYears":96,"academicFieldIds":1694,"indexDatabaseRanking":100},{"id":84,"createTime":85,"updateTime":86,"relativeEntities":1690,"label":1691,"description":1692,"key":92,"publicationTags":1693,"standard":17},[],{"EN":89,"VI":89},{"EN":89,"VI":91},[94],[98,99],{"id":62,"indexDatabase":1696,"url":77,"indexYears":17,"academicFieldIds":1701,"indexDatabaseRanking":17},{"id":64,"createTime":65,"updateTime":66,"relativeEntities":1697,"label":1698,"description":1699,"key":73,"publicationTags":1700,"standard":17},[],{"EN":69,"VI":69},{"VI":71,"EN":72},[75,76],[79,80],{"volume":1703,"pages":1705},{"VOID":1704},"18",{"VOID":1706},"504-509","2016-06-01",2016]